A class of glucosyltransferases that catalyzes the degradation of storage polysaccharides, such as glucose polymers, by phosphorolysis in animals (GLYCOGEN PHOSPHORYLASE) and in plants (STARCH PHOSPHORYLASE).
An enzyme that catalyzes the conversion of ATP and PHOSPHORYLASE B to ADP and PHOSPHORYLASE A.
The inactive form of GLYCOGEN PHOSPHORYLASE that is converted to the active form PHOSPHORYLASE A via phosphorylation by PHOSPHORYLASE KINASE and ATP.
The active form of GLYCOGEN PHOSPHORYLASE that is derived from the phosphorylation of PHOSPHORYLASE B. Phosphorylase a is deactivated via hydrolysis of phosphoserine by PHOSPHORYLASE PHOSPHATASE to form PHOSPHORYLASE B.
An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1.
An enzyme that catalyzes the transfer of ribose from uridine to orthophosphate, forming uracil and ribose 1-phosphate.
An enzyme that catalyzes the transfer of 2-deoxy-D-ribose from THYMIDINE to orthophosphate, thereby liberating thymidine.
An enzyme that catalyzes the degradation of GLYCOGEN in animals by releasing glucose-1-phosphate from the terminal alpha-1,4-glycosidic bond. This enzyme exists in two forms: an active phosphorylated form ( PHOSPHORYLASE A) and an inactive un-phosphorylated form (PHOSPHORYLASE B). Both a and b forms of phosphorylase exist as homodimers. In mammals, the major isozymes of glycogen phosphorylase are found in muscle, liver and brain tissue.
An enzyme that deactivates glycogen phosphorylase a by releasing inorganic phosphate and phosphorylase b, the inactive form. EC 3.1.3.17.
An enzyme of the transferase class that catalyzes the reaction RNA(n+1) and orthophosphate to yield RNA(n) and a nucleoside diphosphate, or the reverse reaction. ADP, IDP, GDP, UDP, and CDP can act as donors in the latter case. (From Dorland, 27th ed) EC 2.7.7.8.
Pentosyltransferases that catalyze the reaction between a pyrimidine nucleoside and orthophosphate to form a free pyrimidine and ribose-5-phosphate.
An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in liver tissue. Mutation of the gene coding this enzyme on chromosome 14 is the cause of GLYCOGEN STORAGE DISEASE TYPE VI.
An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in muscle. Mutation of the gene coding this enzyme is the cause of McArdle disease (GLYCOGEN STORAGE DISEASE TYPE V).
Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another.
An enzyme of the PHOSPHORYLASES family that catalyzes the degradation of starch, a mixture of unbranched AMYLOSE and branched AMYLOPECTIN compounds. This phosphorylase from plants is the counterpart of GLYCOGEN PHOSPHORYLASE in animals that catalyzes the reaction of inorganic phosphate on the terminal alpha-1,4-glycosidic bond at the non-reducing end of glucans resulting in the release of glucose-1-phosphate.
Glycogen is a multibranched polysaccharide of glucose serving as the primary form of energy storage in animals, fungi, and bacteria, stored mainly in liver and muscle tissues. (Two sentences combined as per your request)
An enzyme that catalyzes the transfer of D-glucose from UDPglucose into 1,4-alpha-D-glucosyl chains. EC 2.4.1.11.
Contractile tissue that produces movement in animals.
'Glucosephosphates' are organic compounds resulting from the reaction of glucose with phosphoric acid, playing crucial roles in various metabolic processes, such as energy transfer and storage within cells.
Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position.
An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in brain tissue.
Glycogen stored in the liver. (Dorland, 28th ed)
Enzymes that catalyze the transfer of glucose from a nucleoside diphosphate glucose to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.
A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
The rate dynamics in chemical or physical systems.
Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES.
Nucleosides in which the base moiety is substituted with one or more sulfur atoms.
A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
Ribose substituted in the 1-, 3-, or 5-position by a phosphoric acid moiety.
A hepatic GLYCOGEN STORAGE DISEASE in which there is an apparent deficiency of hepatic phosphorylase (GLYCOGEN PHOSPHORYLASE, LIVER FORM) activity.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme.
An ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. (Stedman, 26th ed)
A group of enzymes removing the SERINE- or THREONINE-bound phosphate groups from a wide range of phosphoproteins, including a number of enzymes which have been phosphorylated under the action of a kinase. (Enzyme Nomenclature, 1992)
Five-carbon furanose sugars in which the OXYGEN is replaced by a NITROGEN atom.
A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.
An enzyme that catalyzes the conversion of phosphorylated, inactive glycogen synthase D to active dephosphoglycogen synthase I. EC 3.1.3.42.
An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule.
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.
Inorganic salts of phosphoric acid.
A family of enzymes that catalyze the exonucleolytic cleavage of RNA. It includes EC 3.1.13.-, EC 3.1.14.-, EC 3.1.15.-, and EC 3.1.16.-. EC 3.1.-
Pyrazolopyrimidine ribonucleosides isolated from Nocardia interforma. They are antineoplastic antibiotics with cytostatic properties.
5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
An oxidoreductase involved in pyrimidine base degradation. It catalyzes the catabolism of THYMINE; URACIL and the chemotherapeutic drug, 5-FLUOROURACIL.
Deoxyribose is a 5-carbon sugar (monosaccharide) that lacks one hydroxyl group at the 2' carbon position, compared to ribose, and is a key component of DNA molecules, forming part of the nucleotides along with phosphate and nitrogenous bases.
A eukayrotic protein serine-threonine phosphatase subtype that dephosphorylates a wide variety of cellular proteins. The enzyme is comprised of a catalytic subunit and regulatory subunit. Several isoforms of the protein phosphatase catalytic subunit exist due to the presence of multiple genes and the alternative splicing of their mRNAs. A large number of proteins have been shown to act as regulatory subunits for this enzyme. Many of the regulatory subunits have additional cellular functions.
A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)
Uracil is a nitrogenous base, specifically a pyrimidine derivative, which constitutes one of the four nucleobases in the nucleic acid of RNA (ribonucleic acid), pairing with adenine via hydrogen bonds during base-pairing. (25 words)
An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH.
A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed)
A heterogenous group of disorders characterized by alterations of mitochondrial metabolism that result in muscle and nervous system dysfunction. These are often multisystemic and vary considerably in age at onset (usually in the first or second decade of life), distribution of affected muscles, severity, and course. (From Adams et al., Principles of Neurology, 6th ed, pp984-5)
The parts of a macromolecule that directly participate in its specific combination with another molecule.
Inosine nucleotides are purine nucleotides that contain inosine, a nucleoside with a hypoxanthine base, which can function as a weak agonist at adenosine receptors and play a role in the salvage pathways of nucleic acid metabolism.
Inorganic or organic salts and esters of arsenic acid.
The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH = log 1/2[1/(H+)], where (H+) is the hydrogen ion concentration in gram equivalents per liter of solution. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding.
A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein.
The sum of the weight of all the atoms in a molecule.
A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels.
A genus of fleshy shelf basidiomycetous fungi, family Schizophyllaceae, order POLYPORALES, growing on woody substrata. It is pathogenic in humans.
A genus of gram-positive, anaerobic bacteria in the family Thermoanaerobacteriaceae. Cultures consist of rods interspersed with coccoid cells.
The release of GLUCOSE from GLYCOGEN by GLYCOGEN PHOSPHORYLASE (phosphorolysis). The released glucose-1-phosphate is then converted to GLUCOSE-6-PHOSPHATE by PHOSPHOGLUCOMUTASE before entering GLYCOLYSIS. Glycogenolysis is stimulated by GLUCAGON or EPINEPHRINE via the activation of PHOSPHORYLASE KINASE.
1,4-alpha-D-Glucan-1,4-alpha-D-glucan 4-alpha-D-glucosyltransferase/dextrin 6 alpha-D-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase (EC 2.4.1.25) and amylo-1,6-glucosidase (EC 3.2.1.33) activities. As a transferase it transfers a segment of a 1,4-alpha-D-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-D-glucan. As a glucosidase it catalyzes the endohydrolysis of 1,6-alpha-D-glucoside linkages at points of branching in chains of 1,4-linked alpha-D-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.
The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety.
The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction.
An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA.
6-(Methylthio)-9-beta-D-ribofuranosylpurine. An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position.
Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
Polyhydric alcohols having no more than one hydroxy group attached to each carbon atom. They are formed by the reduction of the carbonyl group of a sugar to a hydroxyl group.(From Dorland, 28th ed)
Inborn errors of purine-pyrimidine metabolism refer to genetic disorders resulting from defects in the enzymes responsible for the metabolic breakdown and synthesis of purines and pyrimidines, leading to the accumulation of toxic metabolites or deficiency of necessary nucleotides, causing various clinical manifestations such as neurological impairment, kidney problems, and developmental delays.
An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.
The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS.
The 4-carboxyaldehyde form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid.
The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).
Uridine is a nucleoside, specifically a derivative of pyrimidine, that is composed of a uracil molecule joined to a ribose sugar molecule through a β-N1 glycosidic bond, and has significant roles in RNA synthesis, energy transfer, and cell signaling.
A genus of gram-positive, facultatively anaerobic bacteria whose growth is dependent on the presence of a fermentable carbohydrate. It is nonpathogenic to plants and animals, including humans.
Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES.
A key intermediate in carbohydrate metabolism. Serves as a precursor of glycogen, can be metabolized into UDPgalactose and UDPglucuronic acid which can then be incorporated into polysaccharides as galactose and glucuronic acid. Also serves as a precursor of sucrose lipopolysaccharides, and glycosphingolipids.
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES.
A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
A genus of gram-positive, spherical bacteria found in soils and fresh water, and frequently on the skin of man and other animals.
Pentosephosphates are monosaccharides, specifically pentoses, that have a phosphate group attached, playing crucial roles in carbohydrate metabolism, such as being intermediates in the pentose phosphate pathway and serving as precursors for nucleotide synthesis.
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
An antiviral derivative of THYMIDINE used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HERPES SIMPLEX virus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p557)
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p2035)
Inosine 5'-Monophosphate. A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety.
The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Catalyze the hydrolysis of nucleosides with the elimination of ammonia.
Pyrimidinones are heterocyclic organic compounds that consist of a pyrimidine ring fused with a ketone group, which have significant applications in medicinal chemistry due to their wide range of biological activities, including antibacterial, antiviral, and anticancer properties.
Chromatography on non-ionic gels without regard to the mechanism of solute discrimination.
Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.
A site on an enzyme which upon binding of a modulator, causes the enzyme to undergo a conformational change that may alter its catalytic or binding properties.
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics.
An enzyme that catalyzes the phosphorylation of uridine and cytidine to uridine 5'-phosphate and cytidine 5'-phosphate, respectively. ATP, dUTP, dGTP, and dATP are effective phosphate donors. EC 2.7.1.48.
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
Guanine nucleotides which contain deoxyribose as the sugar moiety.
A class of enzymes that transfers nucleotidyl residues. EC 2.7.7.
The region of an enzyme that interacts with its substrate to cause the enzymatic reaction.
A plant species of the genus SOLANUM, family SOLANACEAE. The starchy roots are used as food. SOLANINE is found in green parts.
A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
Inorganic salts of hydrofluoric acid, HF, in which the fluorine atom is in the -1 oxidation state. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Sodium and stannous salts are commonly used in dentifrices.
Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure.
A purine or pyrimidine base bonded to DEOXYRIBOSE.
A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.
A class of carbohydrates that contains five carbon atoms.
Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed)
An enzyme that catalyzes the synthesis of polyadenylic acid from ATP. May be due to the action of RNA polymerase (EC 2.7.7.6) or polynucleotide adenylyltransferase (EC 2.7.7.19). EC 2.7.7.19.
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
A dextrodisaccharide from malt and starch. It is used as a sweetening agent and fermentable intermediate in brewing. (Grant & Hackh's Chemical Dictionary, 5th ed)
A nucleoside consisting of the base guanine and the sugar deoxyribose.
An enzyme that catalyzes the conversion of alpha D-glucose 1-phosphate to alpha D-glucose 6-phosphate. EC 5.4.2.2.
A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4.
Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins.
The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
A phosphoprotein phosphatase subtype that is comprised of a catalytic subunit and two different regulatory subunits. At least two genes encode isoforms of the protein phosphatase catalytic subunit, while several isoforms of regulatory subunits exist due to the presence of multiple genes and the alternative splicing of their mRNAs. Protein phosphatase 2 acts on a broad variety of cellular proteins and may play a role as a regulator of intracellular signaling processes.
Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis.
An enzyme of the transferase class that catalyzes the reaction 5,10-methylenetetrahydrofolate and dUMP to dihydrofolate and dTMP in the synthesis of thymidine triphosphate. (From Dorland, 27th ed) EC 2.1.1.45.
Positively charged atoms, radicals or groups of atoms with a valence of plus 2, which travel to the cathode or negative pole during electrolysis.
A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH.
Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants.
Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position.
A group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate. EC 3.1.3.
A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.
Thymidine is a pyrimidine nucleoside, consisting of a thymine base linked to a deoxyribose sugar by a β-N1-glycosidic bond, which plays a crucial role in DNA replication and repair processes as one of the four nucleosides in DNA.
A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.
Nucleotides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
A family of enzymes that catalyze the endonucleolytic cleavage of RNA. It includes EC 3.1.26.-, EC 3.1.27.-, EC 3.1.30.-, and EC 3.1.31.-.
Oligosaccharides containing two monosaccharide units linked by a glycosidic bond.
A subtype of striated muscle, attached by TENDONS to the SKELETON. Skeletal muscles are innervated and their movement can be consciously controlled. They are also called voluntary muscles.
Antimetabolites that are useful in cancer chemotherapy.
A purine base and a fundamental unit of ADENINE NUCLEOTIDES.
Trehalose is a non-reducing disaccharide composed of two glucose molecules linked by an alpha, alpha-1,1-glycosidic bond, naturally found in some plants and microorganisms, serving as a cryoprotectant and providing cellular protection against various stress conditions.
The composition, conformation, and properties of atoms and molecules, and their reaction and interaction processes.
The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat.

Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts. (1/155)

beta-Adrenoceptor stimulation acts in the heart in part by increasing the phosphorylation state of phospholamban and phospholemman. There is evidence that the beta-adrenoceptor-mediated increase in phospholamban phosphorylation is in part due to inhibition of type 1 phosphatases. The aim of the present study was to elucidate which phosphatases dephosphorylate phospholamban and phospholemman in the human heart. In the past, cardiac serine/threonine phosphatases have been studied using phosphorylase a as substrate. Here, type 1 and type 2A phosphatase activities were studied in preparations from failing human hearts using phosphorylated phospholamban and phospholemman as substrates. Phospholamban and phospholemman phosphatase activity was detectable in human cardiac homogenates. Moreover, using a heparin-Sepharose column, the catalytic subunits of type 1 and type 2A phosphatases could be separated from human ventricles. Okadaic acid and cantharidin inhibited phosphatase activities dephosphorylating phospholamban, phospholemman, and phosphorylase a in homogenates in a concentration-dependent manner. However, okadaic acid was more potent. Cantharidin inhibited type 2A and type 1 activities against all substrates studied with IC50 values <15 nM and >290 nM, respectively. Okadaic acid inhibited type 1 and type 2A phosphatase activities as effectively but 10-30 times more potently than cantharidin. This work provides evidence that in the human heart, type 1 and 2A phosphatases are involved in the dephosphorylation of phospholamban and phospholemman and could play a role in the effects of beta-adrenergic stimulation in the heart.  (+info)

Kinetic study on the dimer-tetramer interconversion of glycogen phosphorylase a. (2/155)

Kinetic theory of dissociating enzyme systems has been applied to a study of the dimer-tetramer interconversion of glycogen phosphorylase a. All kinetic constants for the dissociating-associating reaction of phosphorylase a have been determined. The results indicate that (a) the presence of glucose-1-phosphate has no influence on either the rate of dissociation or the rate of association, and hence does not shift the dimer-tetramer equilibrium of phosphorylase a; (b) the binding og glycogen to the enzyme decreases the association rate of the dimer to form the tetramer, but has no effect on the dissociation rate of the tetramer; (c) both the dimeric and tetrameric form of phosphorylase a can bind glycogen, but the tetrameric form has a lower affinity for glycogen and is catalytically inactive.  (+info)

Effects of microcystins on phosphorylase-a binding to phosphatase-2A: kinetic analysis by surface plasmon resonance biosensor. (3/155)

Cyclic heptapeptide microcystins are a group of hepatoxicants which exert the cytotoxic effects by inhibiting the catalytic activities of phosphatase-2A (PP-2A) and phosphatase-1 (PP-1) and thus disrupt the normal signal transduction pathways. Microcystins interact with PP-2A and PP-1 by a two-step mechanism involving rapid binding and inactivation of protein phosphatase catalytic subunit, followed by a slower covalent interaction. It was proposed that inactivation of PP-2A/PP-1 catalytic activity by microcystins precedes covalent adduct formation. In this study, we used a biosensor based on surface plasmon resonance (SPR) to examine the effects of three microcystins, MCLR, MCRR and MCYR, on the binding between PP-2A and its substrate, phosphorylase-a (PL-a), during the first step of the interaction. The SPR biosensor provides real-time information on the association and dissociation kinetics of PL-a with immobilized PP-2A in the absence and presence of microcystins. It was found that the affinity of PL-a to microcystin-bound PP-2A was four times smaller compared to unbound PP-2A, due to 50% decreases in the association rates and two-fold increases in dissociation rates of PL-a binding to PP-2A. The results suggest that the rapid binding of microcystins to the PP-2A catalytic site leads to the formation of a noncovalent microcystin/PP-2A adduct. While the adduct formation fully inhibits the catalytic activity of PP-2A, it only results in partial inhibition of the substrate binding. The similar effects of the three microcystins on PP-2A suggest that the toxins bind to PP-2A at the same site and cause similar conformational changes. The present work also demonstrates the potential application of biosensor technology in environmental toxicological research.  (+info)

beta2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. (4/155)

BACKGROUND: Recent studies of beta-adrenergic receptor (beta-AR) subtype signaling in in vitro preparations have raised doubts as to whether the cAMP/protein kinase A (PKA) signaling is activated in the same manner in response to beta2-AR versus beta1-AR stimulation. METHODS AND RESULTS: The present study compared, in the intact dog, the magnitude and characteristics of chronotropic, inotropic, and lusitropic effects of cAMP accumulation, PKA activation, and PKA-dependent phosphorylation of key effector proteins in response to beta-AR subtype stimulation. In addition, many of these parameters and L-type Ca2+ current (ICa) were also measured in single canine ventricular myocytes. The results indicate that although the cAMP/PKA-dependent phosphorylation cascade activated by beta1-AR stimulation could explain the resultant modulation of cardiac function, substantial beta2-AR-mediated chronotropic, inotropic, and lusitropic responses occurred in the absence of PKA activation and phosphorylation of nonsarcolemmal proteins, including phospholamban, troponin I, C protein, and glycogen phosphorylase kinase. However, in single canine myocytes, we found that beta2-AR-stimulated increases in both ICa and contraction were abolished by PKA inhibition. Thus, the beta2-AR-directed cAMP/PKA signaling modulates sarcolemmal L-type Ca2+ channels but does not regulate PKA-dependent phosphorylation of cytoplasmic proteins. CONCLUSIONS: These results indicate that the dissociation of beta2-AR signaling from cAMP regulatory systems is only apparent and that beta2-AR-stimulated cAMP/PKA signaling is uncoupled from phosphorylation of nonsarcolemmal regulatory proteins involved in excitation-contraction coupling.  (+info)

The carboxyl-terminal region of the retinoblastoma protein binds non-competitively to protein phosphatase type 1alpha and inhibits catalytic activity. (5/155)

pRB, a negative-growth regulatory protein, is a demonstrated substrate for type 1 serine/threonine protein phosphatases (PP1). In a recent report from this laboratory, we demonstrated that select forms of phosphorylated as well as hypophosphorylated pRB can be found complexed with the alpha-isotype of PP1 (PP1alpha). This complex can also be observed when PP1 is rendered catalytically dead by toxin inhibition. These data suggested to us that pRB may bind to PP1 at one or more sites other than the catalytically active one on the enzyme and that such binding may play a role other than bringing the substrate into contact with the enzyme to facilitate catalysis. To address this possibility we utilized a series of pRB deletion mutants and coprecipitation studies to map the pRB domain involved in binding to PP1. Together with competition assays using in vivo expression of SV40 T-antigen, we show here that the carboxyl-terminal region of pRB is both necessary and sufficient for physical interaction with PP1. Subsequent biochemical analyses demonstrated inhibition of PP1 catalytic activity toward the standard substrate phosphorylase a when this enzyme is bound to pRB containing this region. K(m) and V(max) calculations revealed that pRB binds to PP1 in a non-competitive manner. These data support the notion that pRB, in addition to being a substrate for PP1, also functions as a PP1 inhibitor. The significance of this finding with respect to the functional importance of this interaction is discussed.  (+info)

Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: inhibition and inactivation of glycogen phosphorylase by an activated metabolite. (6/155)

The racemic prodrug BAY R3401 suppresses hepatic glycogenolysis. BAY W1807, the active metabolite of BAY R3401, inhibits muscle glycogen phosphorylase a and b. We investigated whether BAY R3401 reduces hepatic glycogenolysis by allosteric inhibition or by phosphatase-catalyzed inactivation of phosphorylase. In gel-filtered liver extracts, racemic BAY U6751 (containing active BAY W1807) was tested for inhibition of phosphorylase in the glycogenolytic (in which only phosphorylase a is active) and glycogen-synthetic (for the evaluation of a:b ratios) directions. Phosphorylase inactivation by endogenous phosphatase was also studied. In liver extracts, BAY U6751 (0.9-36 micromol/l) inhibited glycogen synthesis by phosphorylase b (notwithstanding the inclusion of AMP), but not by phosphorylase a. Inhibition of phosphorylase-a-catalyzed glycogenolysis was partially relieved by AMP (500 micromol/l). BAY U6751 facilitated phosphorylase-a dephosphorylation. Isolated hepatocytes and perfused livers were tested for BAY R3401-induced changes in phosphorylase-a:b ratios and glycogenolytic output. Though ineffective in extracts, BAY R3401 (0.25 micromol/l-0.5 mmol/l) promoted phosphorylase-a dephosphorylation in hepatocytes. In perfused livers exposed to dibutyryl cAMP (100 micromol/l) for maximal activation of phosphorylase, BAY R3401 (125 micromol/l) inactivated phosphorylase by 63% but glucose output dropped by 83%. Inhibition of glycogenolysis suppressed glucose-6-phosphate (G6P) levels. Activation of glycogen synthase after phosphorylase inactivation depended on the maintenance of G6P levels by supplementing glucose (50 mmol/l). We conclude that the metabolites of BAY R3401 suppress hepatic glycogenolysis by allosteric inhibition and by the dephosphorylation of phosphorylase a.  (+info)

Uric acid inhibits liver phosphorylase a activity under simulated in vivo conditions. (7/155)

We have reported that glycogen synthesis and degradation can occur in vivo without a significant change in the amount of phosphorylase a present. These data suggest the presence of a regulatable mechanism for inhibiting phosphorylase a activity in vivo. Several effectors have been described. AMP stimulates, whereas ADP, ATP, and glucose inhibit activity. Of these effectors, only the glucose concentration changes under normal conditions; thus it could regulate phosphorylase a activity in vivo. We previously have reported that, when all of these effectors were present at physiological concentrations, the net effect was no change in phosphorylase a activity. Addition of caffeine, an independent inhibitor of activity, to the above effectors not only resulted in inhibition but also restored a glucose concentration-dependent inhibition. Because uric acid is an endogenous xanthine derivative, we decided to determine whether it had an effect on phosphorylase a activity. Independently, uric acid did not affect activity; however, when added at a presumed physiological concentration in combination with AMP, ADP, ATP, and glucose, it inhibited activity. A modest but not statistically significant glucose concentration-dependent inhibition was also present. Thus uric acid may play an important role in regulating phosphorylase a activity in vivo.  (+info)

Skeletal muscle glycogen phosphorylase a kinetics: effects of adenine nucleotides and caffeine. (8/155)

This study aimed to determine physiologically relevant kinetic and allosteric effects of P(i), AMP, ADP, and caffeine on isolated skeletal muscle glycogen phosphorylase a (Phos a). In the absence of effectors, Phos a had Vmax = 221 +/- 2 U/mg and Km = 5.6 +/- 0.3 mM P(i) at 30 degrees C. AMP and ADP each increased Phos a Vmax and decreased Km in a dose-dependent manner. AMP was more effective than ADP (e.g., 1 microM AMP vs. ADP: Vmax = 354 +/- 2 vs. 209 +/- 8 U/mg, and Km = 2.3 +/- 0.1 vs. 4.1 +/- 0.3 mM). Both nucleotides were relatively more effective at lower P(i) levels. Experiments simulating a range of contraction (exercise) conditions in which P(i), AMP, and ADP were used at appropriate physiological concentrations demonstrated that each agent singly and in combination influences Phos a activity. Caffeine (50-100 microM) inhibited Phos a (Km approximately 8-14 mM, approximately 40-50% reduction in activity at 2-10 mM P(i)). The present in vitro data support a possible contribution of substrate (P(i)) and allosteric effects to Phos a regulation in many physiological states, independent of covalent modulation of the percentage of total Phos in the Phos a form and suggest that caffeine inhibition of Phos a activity may contribute to the glycogen-sparing effect of caffeine.  (+info)

Phosphorylases are enzymes that catalyze the phosphorolytic cleavage of a bond, often a glycosidic bond, in a carbohydrate molecule, releasing a sugar moiety and a phosphate group. This reaction is important in metabolic pathways such as glycogenolysis, where glycogen is broken down into glucose-1-phosphate by the action of glycogen phosphorylase. The resulting glucose-1-phosphate can then be further metabolized to produce energy. Phosphorylases are widely found in nature and play a crucial role in various biological processes, including energy metabolism and signal transduction.

Phosphorylase Kinase (PhK) is a key enzyme in the regulation of glycogen metabolism, primarily involved in the breakdown of glycogen to glucose-1-phosphate. It is a serine/threonine protein kinase that catalyzes the phosphorylation of glycogen phosphorylase b, an isoform of glycogen phosphorylase, converting it into its active form, glycogen phosphorylase a.

PhK is composed of four different subunits: α, β, γ, and δ. The γ subunit contains the catalytic site, while the other subunits play regulatory roles. PhK itself can be activated by calcium ions (Ca2+) and protein kinase A (PKA)-mediated phosphorylation.

Phosphorylase Kinase is primarily located in the sarcoplasmic reticulum of muscle cells, where it plays a crucial role in regulating energy production during muscle contraction and relaxation. Dysregulation or mutations in PhK have been implicated in several genetic disorders, such as Debré-akaki syndrome, which is characterized by muscle weakness and cardiac abnormalities.

Phosphorylase b is a form of the enzyme glycogen phosphorylase, which is involved in the breakdown of glycogen, a large polymer of glucose, to glucose-1-phosphate. This enzyme plays a crucial role in carbohydrate metabolism, particularly during muscle contraction and liver glycogenolysis (the process of breaking down glycogen in the liver to release glucose into the bloodstream).

Phosphorylase b is an inactive form of the enzyme that can be converted to its active form, phosphorylase a, through the addition of a phosphate group by another enzyme called phosphorylase kinase. This conversion is part of a signaling cascade that activates glycogen breakdown in response to hormonal signals (such as epinephrine or glucagon) and metabolic demands (like muscle contraction).

The interconversion between phosphorylase b and phosphorylase a is an essential mechanism for regulating glycogen metabolism, allowing the body to rapidly respond to changing energy needs.

Phosphorylase a is an enzyme that plays a crucial role in the breakdown and metabolism of glycogen, a complex carbohydrate stored primarily in the liver and muscles. It is a phosphorylated form of the enzyme glycogen phosphorylase, which is activated by the addition of a phosphate group.

Phosphorylase a catalyzes the rate-limiting step in glycogenolysis, the process of breaking down glycogen into glucose-1-phosphate, which can then be converted into glucose and used for energy production. The activation of phosphorylase a is mediated by hormones such as adrenaline (epinephrine) and glucagon, which stimulate the enzyme phosphorylase kinase to add a phosphate group to inactive phosphorylase b, converting it to active phosphorylase a.

Phosphorylase a is composed of two identical subunits, each containing a catalytic site and a regulatory site that binds to ATP, glucose, and other molecules. The enzyme's activity is regulated by several factors, including the concentration of glucose, the presence of calcium ions, and the phosphorylation state of the enzyme.

In summary, Phosphorylase a is a key enzyme in glycogen metabolism that catalyzes the breakdown of glycogen into glucose-1-phosphate, providing energy for the body's cells. Its activity is regulated by hormones and other factors, making it an important component of the body's energy homeostasis.

Purine-nucleoside phosphorylase (PNP) is an enzyme that plays a crucial role in the metabolism of purines, which are essential components of nucleic acids (DNA and RNA). The medical definition of 'Purine-Nucleoside Phosphorylase' refers to the physiological function of this enzyme in the human body.

PNP is responsible for catalyzing the phosphorolytic cleavage of purine nucleosides, such as inosine and guanosine, into their respective purine bases (hypoxanthine and guanine) and ribose-1-phosphate. This reaction is essential for the recycling and salvage of purine bases, allowing the body to conserve energy and resources needed for de novo purine biosynthesis.

In a clinical or medical context, deficiencies in PNP activity can lead to serious consequences, particularly affecting the immune system and the nervous system. A genetic disorder called Purine-Nucleoside Phosphorylase Deficiency (PNP Deficiency) is characterized by significantly reduced or absent PNP enzyme activity, leading to an accumulation of toxic purine nucleosides and deoxypurine nucleosides. This accumulation can cause severe combined immunodeficiency (SCID), neurological impairments, and other complications, making it a critical area of study in medical research.

Uridine phosphorylase is an enzyme that plays a role in the metabolism of nucleosides, specifically uridine. The medical definition of 'uridine phosphorylase' is:

An enzyme (EC 2.4.2.3) involved in the reversible phosphorolysis of uridine to uracil and ribose-1-phosphate. This enzyme also catalyzes the phosphorolytic cleavage of other pyrimidine nucleosides, such as cytidine and thymidine, into their respective bases and ribose-1-phosphate. Uridine phosphorylase has a role in the salvage pathway of pyrimidine nucleotide biosynthesis and is found in various tissues, including the liver, intestines, and blood cells. Deficiency or dysfunction of uridine phosphorylase can lead to impaired nucleotide metabolism and may be associated with certain medical conditions, such as hereditary orotic aciduria.

Thymidine phosphorylase (TP) is an enzyme that plays a role in the metabolism of nucleosides, specifically thymidine. The medical definition of thymidine phosphorylase is:

An enzyme that catalyzes the conversion of thymidine to thymine and deoxyribose-1-phosphate. Thymidine phosphorylase has been identified as a key enzyme in the angiogenic (formation of new blood vessels) pathway, where it facilitates the release of pro-angiogenic factors such as vascular endothelial growth factor (VEGF).

In addition to its role in nucleoside metabolism and angiogenesis, thymidine phosphorylase has been implicated in cancer biology. Increased levels of thymidine phosphorylase have been found in various human cancers, including colorectal, breast, lung, and pancreatic cancers. These high levels of thymidine phosphorylase are associated with poor prognosis and increased angiogenesis, contributing to tumor growth and metastasis.

Thus, thymidine phosphorylase is a crucial enzyme in nucleoside metabolism, angiogenesis, and cancer biology, making it an important target for the development of novel anti-cancer therapies.

Glycogen phosphorylase is an enzyme that plays a crucial role in the breakdown of glycogen, a stored form of glucose, to provide energy for the body's needs. This enzyme is primarily located in the liver and muscles.

In the process of glycogenolysis, glycogen phosphorylase catalyzes the phosphorolytic cleavage of the α-1,4-glycosidic bonds between glucose units in glycogen, releasing glucose-1-phosphate. This reaction does not involve water, unlike hydrolysis, making it more energy efficient. The glucose-1-phosphate produced can then be further metabolized to yield ATP and other energy-rich compounds through the glycolytic pathway.

Glycogen phosphorylase exists in two interconvertible forms: the active a form and the less active b form. The conversion between these forms is regulated by various factors, including hormones (such as insulin, glucagon, and epinephrine), enzymes, and second messengers (like cyclic AMP). Phosphorylation and dephosphorylation of the enzyme are critical in this regulation process. When glycogen phosphorylase is phosphorylated, it becomes activated, leading to increased glycogen breakdown; when it's dephosphorylated, it becomes less active or inactive, slowing down glycogenolysis.

Understanding the function and regulation of glycogen phosphorylase is essential for comprehending energy metabolism, particularly during periods of fasting, exercise, and stress when glucose availability from glycogen stores becomes crucial.

Phosphorylase phosphatase is an enzyme that plays a role in the regulation of glycogen metabolism. It works by removing phosphate groups from glycogen phosphorylase, which is an enzyme that breaks down glycogen into glucose-1-phosphate. The dephosphorylation of glycogen phosphorylase by phosphorylase phosphatase leads to the inactivation of the enzyme and therefore slows down the breakdown of glycogen. Phosphorylase phosphatase is itself regulated by various hormones and signaling molecules, allowing for fine-tuning of glycogen metabolism in response to changes in energy demand.

Polyribonucleotide nucleotidyltransferase (PRNT) is not a commonly used medical term, but it is a biological term that refers to an enzyme class with the ability to add nucleotides to the 3'-hydroxyl end of RNA molecules. These enzymes play a crucial role in various cellular processes, including RNA metabolism and repair. They can be found in different organisms, from bacteria to humans.

One well-known example of a PRNT is the RNA polymerase, which synthesizes RNA using DNA as a template during transcription. Another example is the telomere-associated polyribonucleotide nucleotidyltransferase, also known as TERT (telomerase reverse transcriptase), which adds repetitive DNA sequences to the ends of chromosomes (telomeres) to maintain their length and stability.

While PRNTs have significant biological importance, they are not typically referred to in a medical context unless discussing specific diseases or conditions related to their dysfunction.

Pyrimidine phosphorylases are a group of enzymes that play a crucial role in the metabolism of pyrimidines, which are nitrogenous bases found in nucleic acids such as DNA and RNA. These enzymes catalyze the reversible phosphorolytic cleavage of pyrimidine nucleosides into ribose-1-phosphate and a free base.

There are two main types of pyrimidine phosphorylases: cytosine phosphorylase (CP) and thymidine phosphorylase (TP). CP catalyzes the conversion of cytosine to uracil, while TP converts thymidine to thymine. These enzymes are important in maintaining the balance of pyrimidines in cells and are also involved in the salvage pathway for nucleotide synthesis.

Deficiencies or mutations in these enzymes can lead to various genetic disorders, including neurological and developmental abnormalities. Additionally, TP has been studied as a potential target for cancer therapy due to its role in angiogenesis and tumor growth.

Glycogen phosphorylase, liver form, is an enzyme that plays a crucial role in the breakdown of glycogen, a stored form of glucose, in the liver. This process, known as glycogenolysis, helps regulate blood glucose levels during fasting or periods of increased energy demand.

The liver form of glycogen phosphorylase exists in an inactive state called the "b" form under normal conditions. When stimulated by hormones such as glucagon or epinephrine, it gets converted to its active "a" form through a process called phosphorylation. Once activated, glycogen phosphorylase catalyzes the rate-limiting step of glycogenolysis: the cleavage of a glucose molecule from a glycogen branch, releasing glucose-1-phosphate. This product can then be further metabolized to yield free glucose and provide energy for the body.

In summary, glycogen phosphorylase, liver form, is an essential enzyme in regulating blood glucose levels by breaking down glycogen stores in the liver during periods of increased energy demand or fasting.

Glycogen phosphorylase, muscle form (GP-MM), also known as phosphorylase kinase, is an isoform of the glycogen phosphorylase enzyme that is primarily expressed in skeletal muscle tissue. This enzyme plays a critical role in the breakdown of glycogen, a stored form of glucose, to provide energy for muscle contraction and other cellular processes.

GP-MM is activated by the presence of calcium ions and phosphorylation, which is catalyzed by another enzyme called protein kinase A. Once activated, GP-MM catalyzes the rate-limiting step in glycogenolysis, the process of breaking down glycogen into glucose-1-phosphate, which can then be further metabolized to produce ATP, the primary energy currency of the cell.

Deficiencies in GP-MM function can lead to several inherited muscle disorders, including McArdle disease, a rare genetic disorder characterized by exercise intolerance and muscle cramps due to an inability to break down glycogen and generate energy during muscle contraction.

Pentosyltransferases are a group of enzymes that catalyze the transfer of a pentose (a sugar containing five carbon atoms) molecule from one compound to another. These enzymes play important roles in various biochemical pathways, including the biosynthesis of nucleotides, glycoproteins, and other complex carbohydrates.

One example of a pentosyltransferase is the enzyme that catalyzes the addition of a ribose sugar to form a glycosidic bond with a purine or pyrimidine base during the biosynthesis of nucleotides, which are the building blocks of DNA and RNA.

Another example is the enzyme that adds xylose residues to proteins during the formation of glycoproteins, which are proteins that contain covalently attached carbohydrate chains. These enzymes are essential for many biological processes and have been implicated in various diseases, including cancer and neurodegenerative disorders.

Starch phosphorylase is an enzyme that catalyzes the phosphorolytic cleavage of alpha-1,4 glycosidic bonds in starch and related polysaccharides, releasing alpha-D-glucose 1-phosphate molecules. It is found in various tissues, including muscle and liver, and plays a role in carbohydrate metabolism by helping to regulate the breakdown and synthesis of glycogen, which is a storage form of glucose.

The enzyme works by transferring a phosphate group from inorganic phosphate to the terminal alpha-1,4 linked glucosyl residue of the substrate, resulting in the formation of glucose 1-phosphate and a shortened polysaccharide chain. This reaction is reversible, allowing the enzyme to also participate in glycogen synthesis by adding glucose units to the non-reducing end of the glycogen molecule.

Starch phosphorylase is important for maintaining normal blood glucose levels and providing energy to cells during periods of fasting or exercise. Deficiencies in this enzyme can lead to metabolic disorders, such as glycogen storage disease type VI (Hers disease), which is characterized by the accumulation of abnormal glycogen molecules in the liver and muscle tissue.

Glycogen is a complex carbohydrate that serves as the primary form of energy storage in animals, fungi, and bacteria. It is a polysaccharide consisting of long, branched chains of glucose molecules linked together by glycosidic bonds. Glycogen is stored primarily in the liver and muscles, where it can be quickly broken down to release glucose into the bloodstream during periods of fasting or increased metabolic demand.

In the liver, glycogen plays a crucial role in maintaining blood glucose levels by releasing glucose when needed, such as between meals or during exercise. In muscles, glycogen serves as an immediate energy source for muscle contractions during intense physical activity. The ability to store and mobilize glycogen is essential for the proper functioning of various physiological processes, including athletic performance, glucose homeostasis, and overall metabolic health.

Glycogen synthase is an enzyme (EC 2.4.1.11) that plays a crucial role in the synthesis of glycogen, a polysaccharide that serves as the primary storage form of glucose in animals, fungi, and bacteria. This enzyme catalyzes the transfer of glucosyl residues from uridine diphosphate glucose (UDP-glucose) to the non-reducing end of an growing glycogen chain, thereby elongating it.

Glycogen synthase is regulated by several mechanisms, including allosteric regulation and covalent modification. The activity of this enzyme is inhibited by high levels of intracellular glucose-6-phosphate (G6P) and activated by the binding of glycogen or proteins that bind to glycogen, such as glycogenin. Phosphorylation of glycogen synthase by protein kinases, like glycogen synthase kinase-3 (GSK3), also reduces its activity, while dephosphorylation by protein phosphatases enhances it.

The regulation of glycogen synthase is critical for maintaining glucose homeostasis and energy balance in the body. Dysregulation of this enzyme has been implicated in several metabolic disorders, including type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).

A muscle is a soft tissue in our body that contracts to produce force and motion. It is composed mainly of specialized cells called muscle fibers, which are bound together by connective tissue. There are three types of muscles: skeletal (voluntary), smooth (involuntary), and cardiac. Skeletal muscles attach to bones and help in movement, while smooth muscles are found within the walls of organs and blood vessels, helping with functions like digestion and circulation. Cardiac muscle is the specific type that makes up the heart, allowing it to pump blood throughout the body.

Glucose phosphates are organic compounds that result from the reaction of glucose (a simple sugar) with phosphate groups. These compounds play a crucial role in various metabolic processes, particularly in energy metabolism within cells. The addition of phosphate groups to glucose makes it more reactive and enables it to undergo further reactions that lead to the formation of important molecules such as adenosine triphosphate (ATP), which is a primary source of energy for cellular functions.

One notable example of a glucose phosphate is glucose 1-phosphate, which is an intermediate in several metabolic pathways, including glycogenesis (the process of forming glycogen, a storage form of glucose) and glycolysis (the breakdown of glucose to release energy). Another example is glucose 6-phosphate, which is a key regulator of carbohydrate metabolism and serves as an important intermediate in the pentose phosphate pathway, a metabolic route that generates reducing equivalents (NADPH) and ribose sugars for nucleotide synthesis.

In summary, glucose phosphates are essential compounds in cellular metabolism, facilitating energy production, storage, and utilization.

Adenosine monophosphate (AMP) is a nucleotide that is the monophosphate ester of adenosine, consisting of the nitrogenous base adenine attached to the 1' carbon atom of ribose via a β-N9-glycosidic bond, which in turn is esterified to a phosphate group. It is an important molecule in biological systems as it plays a key role in cellular energy transfer and storage, serving as a precursor to other nucleotides such as ADP and ATP. AMP is also involved in various signaling pathways and can act as a neurotransmitter in the central nervous system.

Glycogen phosphorylase, brain form (also known as glycogen phosphorylase brain isoform or PYGB) is an enzyme that plays a crucial role in the breakdown of glycogen, which is a stored form of glucose, to provide energy for the brain. This enzyme is primarily expressed in the brain and is responsible for the release of glucose-1-phosphate from glycogen during periods of low glucose availability or increased energy demand.

Glycogen phosphorylase brain form functions as a dimer, and its activity is regulated by various factors such as phosphorylation, allosteric effectors (like AMP, ADP, and glucose-6-phosphate), and protein-protein interactions. The enzyme's role in the brain's energy metabolism makes it an essential component of maintaining proper neurological function and overall brain health.

Dysregulation or mutations in this gene can lead to various neurological disorders, including Lafora disease, a rare inherited form of progressive myoclonic epilepsy characterized by the formation of abnormal glycogen structures called Lafora bodies.

Liver glycogen is the reserve form of glucose stored in hepatocytes (liver cells) for the maintenance of normal blood sugar levels. It is a polysaccharide, a complex carbohydrate, that is broken down into glucose molecules when blood glucose levels are low. This process helps to maintain the body's energy needs between meals and during periods of fasting or exercise. The amount of glycogen stored in the liver can vary depending on factors such as meal consumption, activity level, and insulin regulation.

Glucosyltransferases (GTs) are a group of enzymes that catalyze the transfer of a glucose molecule from an activated donor to an acceptor molecule, resulting in the formation of a glycosidic bond. These enzymes play crucial roles in various biological processes, including the biosynthesis of complex carbohydrates, cell wall synthesis, and protein glycosylation. In some cases, GTs can also contribute to bacterial pathogenesis by facilitating the attachment of bacteria to host tissues through the formation of glucans, which are polymers of glucose molecules.

GTs can be classified into several families based on their sequence similarities and catalytic mechanisms. The donor substrates for GTs are typically activated sugars such as UDP-glucose, TDP-glucose, or GDP-glucose, which serve as the source of the glucose moiety that is transferred to the acceptor molecule. The acceptor can be a wide range of molecules, including other sugars, proteins, lipids, or small molecules.

In the context of human health and disease, GTs have been implicated in various pathological conditions, such as cancer, inflammation, and microbial infections. For example, some GTs can modify proteins on the surface of cancer cells, leading to increased cell proliferation, migration, and invasion. Additionally, GTs can contribute to bacterial resistance to antibiotics by modifying the structure of bacterial cell walls or by producing biofilms that protect bacteria from host immune responses and antimicrobial agents.

Overall, Glucosyltransferases are essential enzymes involved in various biological processes, and their dysregulation has been associated with several human diseases. Therefore, understanding the structure, function, and regulation of GTs is crucial for developing novel therapeutic strategies to target these enzymes and treat related pathological conditions.

Glycogen storage disease (GSD) is a group of rare inherited metabolic disorders that affect the body's ability to break down and store glycogen, a complex carbohydrate that serves as the primary form of energy storage in the body. These diseases are caused by deficiencies or dysfunction in enzymes involved in the synthesis, degradation, or transport of glycogen within cells.

There are several types of GSDs, each with distinct clinical presentations and affected organs. The most common type is von Gierke disease (GSD I), which primarily affects the liver and kidneys. Other types include Pompe disease (GSD II), McArdle disease (GSD V), Cori disease (GSD III), Andersen disease (GSD IV), and others.

Symptoms of GSDs can vary widely depending on the specific type, but may include:

* Hypoglycemia (low blood sugar)
* Growth retardation
* Hepatomegaly (enlarged liver)
* Muscle weakness and cramping
* Cardiomyopathy (heart muscle disease)
* Respiratory distress
* Developmental delays

Treatment for GSDs typically involves dietary management, such as frequent feedings or a high-protein, low-carbohydrate diet. In some cases, enzyme replacement therapy may be used to manage symptoms. The prognosis for individuals with GSDs depends on the specific type and severity of the disorder.

I believe there may be some confusion in your question. "Rabbits" is a common name used to refer to the Lagomorpha species, particularly members of the family Leporidae. They are small mammals known for their long ears, strong legs, and quick reproduction.

However, if you're referring to "rabbits" in a medical context, there is a term called "rabbit syndrome," which is a rare movement disorder characterized by repetitive, involuntary movements of the fingers, resembling those of a rabbit chewing. It is also known as "finger-chewing chorea." This condition is usually associated with certain medications, particularly antipsychotics, and typically resolves when the medication is stopped or adjusted.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Purine nucleosides are fundamental components of nucleic acids, which are the genetic materials found in all living organisms. A purine nucleoside is composed of a purine base (either adenine or guanine) linked to a sugar molecule, specifically ribose in the case of purine nucleosides.

The purine base and sugar moiety are joined together through a glycosidic bond at the 1' position of the sugar. These nucleosides play crucial roles in various biological processes, including energy transfer, signal transduction, and as precursors for the biosynthesis of DNA and RNA.

In the human body, purine nucleosides can be derived from the breakdown of endogenous nucleic acids or through the dietary intake of nucleoproteins. They are further metabolized to form uric acid, which is eventually excreted in the urine. Elevated levels of uric acid in the body can lead to the formation of uric acid crystals and contribute to the development of gout or kidney stones.

Thionucleosides are a type of modified nucleoside where the oxygen atom in the sugar component (ribose or deoxyribose) is replaced by a sulfur atom. This modification can occur naturally or be introduced synthetically. The resulting compounds have been studied for their potential biological activity, including antiviral and anticancer properties. However, they are not typically used as a standard medical treatment at this time.

Inosine is not a medical condition but a naturally occurring compound called a nucleoside, which is formed from the combination of hypoxanthine and ribose. It is an intermediate in the metabolic pathways of purine nucleotides, which are essential components of DNA and RNA. Inosine has been studied for its potential therapeutic benefits in various medical conditions, including neurodegenerative disorders, cardiovascular diseases, and cancer. However, more research is needed to fully understand its mechanisms and clinical applications.

Ribose monophosphates are organic compounds that play a crucial role in the metabolism of cells, particularly in energy transfer and nucleic acid synthesis. A ribose monophosphate is formed by the attachment of a phosphate group to a ribose molecule, which is a type of sugar known as a pentose.

In biochemistry, there are two important ribose monophosphates:

1. Alpha-D-Ribose 5-Phosphate (ADP-Ribose): This compound serves as an essential substrate in various cellular processes, including DNA repair, chromatin remodeling, and protein modification. The enzyme that catalyzes the formation of ADP-ribose is known as poly(ADP-ribose) polymerase (PARP).
2. Ribulose 5-Phosphate: This compound is a key intermediate in the Calvin cycle, which is the process by which plants and some bacteria convert carbon dioxide into glucose during photosynthesis. Ribulose 5-phosphate is formed from ribose 5-phosphate through a series of enzymatic reactions.

Ribose monophosphates are essential for the proper functioning of cells and have implications in various physiological processes, as well as in certain disease states.

Glycogen Storage Disease Type VI, also known as Hers disease, is a rare inherited metabolic disorder caused by deficiency of the liver enzyme called glycogen phosphorylase. This enzyme is responsible for breaking down glycogen, which is a stored form of glucose, into glucose-1-phosphate during the process of glycogenolysis.

In GSD Type VI, the lack of this enzyme leads to an abnormal accumulation of glycogen in the liver, causing hepatomegaly (enlarged liver) and elevated liver enzymes. The symptoms of this condition are usually milder compared to other types of GSD, and may include fatigue, weakness, and hypoglycemia (low blood sugar), especially after prolonged fasting or physical exertion.

The diagnosis of GSD Type VI is typically made through biochemical tests that measure the activity of the glycogen phosphorylase enzyme in liver tissue, as well as genetic testing to identify mutations in the gene responsible for the enzyme's production. Treatment may involve dietary management, such as frequent feeding and avoidance of prolonged fasting, to prevent hypoglycemia. In some cases, medication may be necessary to manage symptoms and prevent complications.

The liver is a large, solid organ located in the upper right portion of the abdomen, beneath the diaphragm and above the stomach. It plays a vital role in several bodily functions, including:

1. Metabolism: The liver helps to metabolize carbohydrates, fats, and proteins from the food we eat into energy and nutrients that our bodies can use.
2. Detoxification: The liver detoxifies harmful substances in the body by breaking them down into less toxic forms or excreting them through bile.
3. Synthesis: The liver synthesizes important proteins, such as albumin and clotting factors, that are necessary for proper bodily function.
4. Storage: The liver stores glucose, vitamins, and minerals that can be released when the body needs them.
5. Bile production: The liver produces bile, a digestive juice that helps to break down fats in the small intestine.
6. Immune function: The liver plays a role in the immune system by filtering out bacteria and other harmful substances from the blood.

Overall, the liver is an essential organ that plays a critical role in maintaining overall health and well-being.

Enzyme activation refers to the process by which an enzyme becomes biologically active and capable of carrying out its specific chemical or biological reaction. This is often achieved through various post-translational modifications, such as proteolytic cleavage, phosphorylation, or addition of cofactors or prosthetic groups to the enzyme molecule. These modifications can change the conformation or structure of the enzyme, exposing or creating a binding site for the substrate and allowing the enzymatic reaction to occur.

For example, in the case of proteolytic cleavage, an inactive precursor enzyme, known as a zymogen, is cleaved into its active form by a specific protease. This is seen in enzymes such as trypsin and chymotrypsin, which are initially produced in the pancreas as inactive precursors called trypsinogen and chymotrypsinogen, respectively. Once they reach the small intestine, they are activated by enteropeptidase, a protease that cleaves a specific peptide bond, releasing the active enzyme.

Phosphorylation is another common mechanism of enzyme activation, where a phosphate group is added to a specific serine, threonine, or tyrosine residue on the enzyme by a protein kinase. This modification can alter the conformation of the enzyme and create a binding site for the substrate, allowing the enzymatic reaction to occur.

Enzyme activation is a crucial process in many biological pathways, as it allows for precise control over when and where specific reactions take place. It also provides a mechanism for regulating enzyme activity in response to various signals and stimuli, such as hormones, neurotransmitters, or changes in the intracellular environment.

Glucose-6-phosphate (G6P) is a vital intermediate compound in the metabolism of glucose, which is a simple sugar that serves as a primary source of energy for living organisms. G6P plays a critical role in both glycolysis and gluconeogenesis pathways, contributing to the regulation of blood glucose levels and energy production within cells.

In biochemistry, glucose-6-phosphate is defined as:

A hexose sugar phosphate ester formed by the phosphorylation of glucose at the 6th carbon atom by ATP in a reaction catalyzed by the enzyme hexokinase or glucokinase. This reaction is the first step in both glycolysis and glucose storage (glycogen synthesis) processes, ensuring that glucose can be effectively utilized for energy production or stored for later use.

G6P serves as a crucial metabolic branch point, leading to various pathways such as:

1. Glycolysis: In the presence of sufficient ATP and NAD+ levels, G6P is further metabolized through glycolysis to generate pyruvate, which enters the citric acid cycle for additional energy production in the form of ATP, NADH, and FADH2.
2. Gluconeogenesis: During periods of low blood glucose levels, G6P can be synthesized back into glucose through the gluconeogenesis pathway, primarily occurring in the liver and kidneys. This process helps maintain stable blood glucose concentrations and provides energy to cells when dietary intake is insufficient.
3. Pentose phosphate pathway (PPP): A portion of G6P can be shunted into the PPP, an alternative metabolic route that generates NADPH, ribose-5-phosphate for nucleotide synthesis, and erythrose-4-phosphate for aromatic amino acid production. The PPP is essential in maintaining redox balance within cells and supporting biosynthetic processes.

Overall, glucose-6-phosphate plays a critical role as a central metabolic intermediate, connecting various pathways to regulate energy homeostasis, redox balance, and biosynthesis in response to cellular demands and environmental cues.

Phosphoprotein phosphatases (PPPs) are a family of enzymes that play a crucial role in the regulation of various cellular processes by removing phosphate groups from serine, threonine, and tyrosine residues on proteins. Phosphorylation is a post-translational modification that regulates protein function, localization, and stability, and dephosphorylation by PPPs is essential for maintaining the balance of this regulation.

The PPP family includes several subfamilies, such as PP1, PP2A, PP2B (also known as calcineurin), PP4, PP5, and PP6. Each subfamily has distinct substrate specificities and regulatory mechanisms. For example, PP1 and PP2A are involved in the regulation of metabolism, signal transduction, and cell cycle progression, while PP2B is involved in immune response and calcium signaling.

Dysregulation of PPPs has been implicated in various diseases, including cancer, neurodegenerative disorders, and cardiovascular disease. Therefore, understanding the function and regulation of PPPs is important for developing therapeutic strategies to target these diseases.

Imino furanoses are not a recognized medical term, but they may be referred to in the field of biochemistry and carbohydrate research. In this context, imino furanoses are a type of sugar ring structure that contains an imine group (-C=N-) instead of the usual oxygen atom in the furanose form of sugars. Imino furanoses can be formed under certain conditions during chemical reactions involving carbohydrates, but they are not typically found in biological systems.

Substrate specificity in the context of medical biochemistry and enzymology refers to the ability of an enzyme to selectively bind and catalyze a chemical reaction with a particular substrate (or a group of similar substrates) while discriminating against other molecules that are not substrates. This specificity arises from the three-dimensional structure of the enzyme, which has evolved to match the shape, charge distribution, and functional groups of its physiological substrate(s).

Substrate specificity is a fundamental property of enzymes that enables them to carry out highly selective chemical transformations in the complex cellular environment. The active site of an enzyme, where the catalysis takes place, has a unique conformation that complements the shape and charge distribution of its substrate(s). This ensures efficient recognition, binding, and conversion of the substrate into the desired product while minimizing unwanted side reactions with other molecules.

Substrate specificity can be categorized as:

1. Absolute specificity: An enzyme that can only act on a single substrate or a very narrow group of structurally related substrates, showing no activity towards any other molecule.
2. Group specificity: An enzyme that prefers to act on a particular functional group or class of compounds but can still accommodate minor structural variations within the substrate.
3. Broad or promiscuous specificity: An enzyme that can act on a wide range of structurally diverse substrates, albeit with varying catalytic efficiencies.

Understanding substrate specificity is crucial for elucidating enzymatic mechanisms, designing drugs that target specific enzymes or pathways, and developing biotechnological applications that rely on the controlled manipulation of enzyme activities.

Glycogen Synthase-D Phosphatase is not a commonly used medical term, but I can provide you with some information about Glycogen Synthase and Phosphatases that might help.

Glycogen synthase is an enzyme that plays a crucial role in the synthesis of glycogen, which is a form of energy storage in the body, mainly in the liver and muscles. The activity of this enzyme is regulated by phosphorylation and dephosphorylation, which are chemical reactions that add or remove phosphate groups to/from the enzyme, respectively.

Phosphatases are a group of enzymes that catalyze the removal of phosphate groups from various substrates, including proteins like glycogen synthase. Specifically, Glycogen Synthase-D Phosphatase refers to a type of phosphatase that dephosphorylates and activates glycogen synthase by removing phosphate groups from it. This activation leads to increased glycogen synthesis in the body.

Therefore, Glycogen Synthase-D Phosphatase is an enzyme responsible for dephosphorylating and activating glycogen synthase, thereby promoting glycogen storage in the body.

Floxuridine is a chemotherapeutic antimetabolite medication that is primarily used in the treatment of colon cancer. It is a fluorinated pyrimidine nucleoside analogue, which means it is similar in structure to the building blocks of DNA and RNA, and can be incorporated into these molecules during cell division, disrupting their normal function and preventing cell replication.

Floxuridine works by inhibiting the enzyme thymidylate synthase, which is necessary for the synthesis of thymidine, a nucleoside that is essential for DNA replication. By blocking this enzyme, floxuridine can prevent the growth and proliferation of cancer cells.

Floxuridine is often used in combination with other chemotherapy drugs as part of a treatment regimen for colon cancer. It may be administered intravenously or via continuous infusion, depending on the specific treatment plan. As with all chemotherapy drugs, floxuridine can have significant side effects, including nausea, vomiting, diarrhea, and myelosuppression (suppression of bone marrow function), which can lead to anemia, neutropenia, and thrombocytopenia.

Pyridoxal phosphate (PLP) is the active form of vitamin B6 and functions as a cofactor in various enzymatic reactions in the human body. It plays a crucial role in the metabolism of amino acids, carbohydrates, lipids, and neurotransmitters. Pyridoxal phosphate is involved in more than 140 different enzyme-catalyzed reactions, making it one of the most versatile cofactors in human biochemistry.

As a cofactor, pyridoxal phosphate helps enzymes carry out their functions by facilitating chemical transformations in substrates (the molecules on which enzymes act). In particular, PLP is essential for transamination, decarboxylation, racemization, and elimination reactions involving amino acids. These processes are vital for the synthesis and degradation of amino acids, neurotransmitters, hemoglobin, and other crucial molecules in the body.

Pyridoxal phosphate is formed from the conversion of pyridoxal (a form of vitamin B6) by the enzyme pyridoxal kinase, using ATP as a phosphate donor. The human body obtains vitamin B6 through dietary sources such as whole grains, legumes, vegetables, nuts, and animal products like poultry, fish, and pork. It is essential to maintain adequate levels of pyridoxal phosphate for optimal enzymatic function and overall health.

Deoxyadenosine is a chemical compound that is a component of DNA, one of the nucleic acids that make up the genetic material of living organisms. Specifically, deoxyadenosine is a nucleoside, which is a molecule consisting of a sugar (in this case, deoxyribose) bonded to a nitrogenous base (in this case, adenine).

Deoxyribonucleosides like deoxyadenosine are the building blocks of DNA, along with phosphate groups. In DNA, deoxyadenosine pairs with thymidine via hydrogen bonds to form one of the four rungs in the twisted ladder structure of the double helix.

It is important to note that there is a similar compound called adenosine, which contains an extra oxygen atom on the sugar molecule (making it a ribonucleoside) and is a component of RNA, another nucleic acid involved in protein synthesis and other cellular processes.

Glucose is a simple monosaccharide (or single sugar) that serves as the primary source of energy for living organisms. It's a fundamental molecule in biology, often referred to as "dextrose" or "grape sugar." Glucose has the molecular formula C6H12O6 and is vital to the functioning of cells, especially those in the brain and nervous system.

In the body, glucose is derived from the digestion of carbohydrates in food, and it's transported around the body via the bloodstream to cells where it can be used for energy. Cells convert glucose into a usable form through a process called cellular respiration, which involves a series of metabolic reactions that generate adenosine triphosphate (ATP)—the main currency of energy in cells.

Glucose is also stored in the liver and muscles as glycogen, a polysaccharide (multiple sugar) that can be broken down back into glucose when needed for energy between meals or during physical activity. Maintaining appropriate blood glucose levels is crucial for overall health, and imbalances can lead to conditions such as diabetes mellitus.

Phosphates, in a medical context, refer to the salts or esters of phosphoric acid. Phosphates play crucial roles in various biological processes within the human body. They are essential components of bones and teeth, where they combine with calcium to form hydroxyapatite crystals. Phosphates also participate in energy transfer reactions as phosphate groups attached to adenosine diphosphate (ADP) and adenosine triphosphate (ATP). Additionally, they contribute to buffer systems that help maintain normal pH levels in the body.

Abnormal levels of phosphates in the blood can indicate certain medical conditions. High phosphate levels (hyperphosphatemia) may be associated with kidney dysfunction, hyperparathyroidism, or excessive intake of phosphate-containing products. Low phosphate levels (hypophosphatemia) might result from malnutrition, vitamin D deficiency, or certain diseases affecting the small intestine or kidneys. Both hypophosphatemia and hyperphosphatemia can have significant impacts on various organ systems and may require medical intervention.

Exoribonucleases are a type of enzyme that degrade RNA molecules in a process called exoribonucleolysis. They remove nucleotides from the end of an RNA strand, working their way inwards towards the middle of the strand. Exoribonucleases can be specific for single-stranded or double-stranded RNA, and some can discriminate between different types of RNA molecules based on sequence or structure. They play important roles in various cellular processes, including RNA degradation, quality control, and maturation.

Formycins are a group of antibiotics that are derived from certain strains of Streptomyces bacteria. They include formycin B (also known as pyrazofurin), which is an antiviral and antimetabolite drug that works by interfering with the production of genetic material in cells. Formycins are not widely used in clinical medicine due to their potential toxicity and the availability of other effective antibiotics and antiviral drugs.

Bromouracil is a chemical compound that is used in the synthesis of DNA. It is a brominated derivative of uracil, which is one of the nucleobases found in RNA. Bromouracil can be incorporated into DNA during replication in place of thymine, another nucleobase. This can lead to mutations in the DNA because bromouracil behaves differently from thymine in certain chemical reactions.

Bromouracil is not typically found in living organisms and is not considered to be a normal part of the genetic material. It may be used in research settings to study the mechanisms of DNA replication and mutation. In clinical medicine, bromouracil has been used in the treatment of psoriasis, a skin condition characterized by red, scaly patches. However, its use in this context is not common.

It is important to note that bromouracil can have toxic effects and should be handled with care. It can cause irritation to the skin and eyes, and prolonged exposure may lead to more serious health problems. If you have any questions about bromouracil or its use, it is best to speak with a healthcare professional or a qualified scientist.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Macromolecular substances, also known as macromolecules, are large, complex molecules made up of repeating subunits called monomers. These substances are formed through polymerization, a process in which many small molecules combine to form a larger one. Macromolecular substances can be naturally occurring, such as proteins, DNA, and carbohydrates, or synthetic, such as plastics and synthetic fibers.

In the context of medicine, macromolecular substances are often used in the development of drugs and medical devices. For example, some drugs are designed to bind to specific macromolecules in the body, such as proteins or DNA, in order to alter their function and produce a therapeutic effect. Additionally, macromolecular substances may be used in the creation of medical implants, such as artificial joints and heart valves, due to their strength and durability.

It is important for healthcare professionals to have an understanding of macromolecular substances and how they function in the body, as this knowledge can inform the development and use of medical treatments.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Deoxyribose is a type of sugar that makes up the structural backbone of DNA (deoxyribonucleic acid), one of the two main types of nucleic acids in cells. The chemical formula for deoxyribose is C5H10O4, and it has a five-carbon ring structure with four hydroxyl (-OH) groups and one hydrogen atom attached to the carbons.

The key difference between deoxyribose and ribose, which makes up the structural backbone of RNA (ribonucleic acid), is that deoxyribose lacks a hydroxyl group on the second carbon atom in its ring structure. This small difference has significant implications for the structure and function of DNA compared to RNA.

Deoxyribose plays an essential role in the replication, transcription, and repair of genetic material in cells. It forms the sugar-phosphate backbone of DNA by linking with phosphate groups through ester bonds between the 3' carbon atom of one deoxyribose molecule and the 5' carbon atom of another, creating a long, twisted ladder-like structure known as a double helix. The nitrogenous bases adenine, thymine, guanine, and cytosine attach to the 1' carbon atom of each deoxyribose molecule in the DNA strand, forming pairs that are complementary to each other (adenine with thymine and guanine with cytosine).

Overall, deoxyribose is a crucial component of DNA, enabling the storage and transmission of genetic information from one generation to the next.

Protein Phosphatase 1 (PP1) is a type of serine/threonine protein phosphatase that plays a crucial role in the regulation of various cellular processes, including metabolism, signal transduction, and cell cycle progression. PP1 functions by removing phosphate groups from specific serine and threonine residues on target proteins, thereby reversing the effects of protein kinases and controlling protein activity, localization, and stability.

PP1 is a highly conserved enzyme found in eukaryotic cells and is composed of a catalytic subunit associated with one or more regulatory subunits that determine its substrate specificity, subcellular localization, and regulation. The human genome encodes several isoforms of the PP1 catalytic subunit, including PP1α, PP1β/δ, and PP1γ, which share a high degree of sequence similarity and functional redundancy.

PP1 has been implicated in various physiological processes, such as muscle contraction, glycogen metabolism, DNA replication, transcription, and RNA processing. Dysregulation of PP1 activity has been associated with several pathological conditions, including neurodegenerative diseases, cancer, and diabetes. Therefore, understanding the molecular mechanisms that regulate PP1 function is essential for developing novel therapeutic strategies to treat these disorders.

Glucagon is a hormone produced by the alpha cells of the pancreas. Its main function is to regulate glucose levels in the blood by stimulating the liver to convert stored glycogen into glucose, which can then be released into the bloodstream. This process helps to raise blood sugar levels when they are too low, such as during hypoglycemia.

Glucagon is a 29-amino acid polypeptide that is derived from the preproglucagon protein. It works by binding to glucagon receptors on liver cells, which triggers a series of intracellular signaling events that lead to the activation of enzymes involved in glycogen breakdown.

In addition to its role in glucose regulation, glucagon has also been shown to have other physiological effects, such as promoting lipolysis (the breakdown of fat) and inhibiting gastric acid secretion. Glucagon is often used clinically in the treatment of hypoglycemia, as well as in diagnostic tests to assess pancreatic function.

Uracil is not a medical term, but it is a biological molecule. Medically or biologically, uracil can be defined as one of the four nucleobases in the nucleic acid of RNA (ribonucleic acid) that is linked to a ribose sugar by an N-glycosidic bond. It forms base pairs with adenine in double-stranded RNA and DNA. Uracil is a pyrimidine derivative, similar to thymine found in DNA, but it lacks the methyl group (-CH3) that thymine has at the 5 position of its ring.

Cyclic adenosine monophosphate (cAMP) is a key secondary messenger in many biological processes, including the regulation of metabolism, gene expression, and cellular excitability. It is synthesized from adenosine triphosphate (ATP) by the enzyme adenylyl cyclase and is degraded by the enzyme phosphodiesterase.

In the body, cAMP plays a crucial role in mediating the effects of hormones and neurotransmitters on target cells. For example, when a hormone binds to its receptor on the surface of a cell, it can activate a G protein, which in turn activates adenylyl cyclase to produce cAMP. The increased levels of cAMP then activate various effector proteins, such as protein kinases, which go on to regulate various cellular processes.

Overall, the regulation of cAMP levels is critical for maintaining proper cellular function and homeostasis, and abnormalities in cAMP signaling have been implicated in a variety of diseases, including cancer, diabetes, and neurological disorders.

Guanosine is a nucleoside that consists of a guanine base linked to a ribose sugar molecule through a beta-N9-glycosidic bond. It plays a crucial role in various biological processes, such as serving as a building block for DNA and RNA during replication and transcription. Guanosine triphosphate (GTP) and guanosine diphosphate (GDP) are important energy carriers and signaling molecules involved in intracellular regulation. Additionally, guanosine has been studied for its potential role as a neuroprotective agent and possible contribution to cell-to-cell communication.

Mitochondrial Encephalomyopathies are a group of genetic disorders that primarily affect the mitochondria, which are the energy-producing structures in cells. "Encephalo" refers to the brain, while "myopathy" refers to muscle disease. Therefore, Mitochondrial Encephalomyopathies are conditions that cause both neurological and muscular symptoms due to impaired mitochondrial function.

These disorders can affect any organ in the body, but they primarily impact the brain, nerves, and muscles. Symptoms may include muscle weakness, seizures, developmental delays, hearing loss, vision loss, heart problems, and lactic acidosis (a buildup of lactic acid in the blood).

Mitochondrial Encephalomyopathies can be caused by mutations in either the mitochondrial DNA or nuclear DNA. They are often inherited from the mother, as mitochondria are passed down through the maternal line. However, some cases can also result from new mutations that occur spontaneously.

Due to the complex nature of these disorders and their varying symptoms, diagnosis and treatment can be challenging. Treatment typically focuses on managing specific symptoms and may include medications, dietary changes, and physical therapy.

In the context of medical and biological sciences, a "binding site" refers to a specific location on a protein, molecule, or cell where another molecule can attach or bind. This binding interaction can lead to various functional changes in the original protein or molecule. The other molecule that binds to the binding site is often referred to as a ligand, which can be a small molecule, ion, or even another protein.

The binding between a ligand and its target binding site can be specific and selective, meaning that only certain ligands can bind to particular binding sites with high affinity. This specificity plays a crucial role in various biological processes, such as signal transduction, enzyme catalysis, or drug action.

In the case of drug development, understanding the location and properties of binding sites on target proteins is essential for designing drugs that can selectively bind to these sites and modulate protein function. This knowledge can help create more effective and safer therapeutic options for various diseases.

Inosine nucleotides are chemical compounds that play a role in the metabolism of nucleic acids, which are the building blocks of DNA and RNA. Inosine is a purine nucleoside that is formed when adenosine (a normal component of DNA and RNA) is deaminated, or has an amino group (-NH2) removed from its structure.

Inosine nucleotides are important in the salvage pathway of nucleotide synthesis, which allows cells to recycle existing nucleotides rather than synthesizing them entirely from scratch. Inosine nucleotides can be converted back into adenosine nucleotides through a process called reversal of deamination.

Inosine nucleotides also have important functions in the regulation of gene expression and in the response to cellular stress. For example, they can act as signaling molecules that activate various enzymes and pathways involved in DNA repair, apoptosis (programmed cell death), and other cellular processes.

Inosine nucleotides have been studied for their potential therapeutic uses in a variety of conditions, including neurological disorders, cancer, and viral infections. However, more research is needed to fully understand their mechanisms of action and potential benefits.

Arsenates are salts or esters of arsenic acid (AsO4). They contain the anion AsO4(3-), which consists of an arsenic atom bonded to four oxygen atoms in a tetrahedral arrangement. Arsenates can be found in various minerals, and they have been used in pesticides, wood preservatives, and other industrial applications. However, arsenic is highly toxic to humans and animals, so exposure to arsenates should be limited. Long-term exposure to arsenic can cause skin lesions, cancer, and damage to the nervous system, among other health problems.

Hydrogen-ion concentration, also known as pH, is a measure of the acidity or basicity of a solution. It is defined as the negative logarithm (to the base 10) of the hydrogen ion activity in a solution. The standard unit of measurement is the pH unit. A pH of 7 is neutral, less than 7 is acidic, and greater than 7 is basic.

In medical terms, hydrogen-ion concentration is important for maintaining homeostasis within the body. For example, in the stomach, a high hydrogen-ion concentration (low pH) is necessary for the digestion of food. However, in other parts of the body such as blood, a high hydrogen-ion concentration can be harmful and lead to acidosis. Conversely, a low hydrogen-ion concentration (high pH) in the blood can lead to alkalosis. Both acidosis and alkalosis can have serious consequences on various organ systems if not corrected.

"Inbred strains of rats" are genetically identical rodents that have been produced through many generations of brother-sister mating. This results in a high degree of homozygosity, where the genes at any particular locus in the genome are identical in all members of the strain.

Inbred strains of rats are widely used in biomedical research because they provide a consistent and reproducible genetic background for studying various biological phenomena, including the effects of drugs, environmental factors, and genetic mutations on health and disease. Additionally, inbred strains can be used to create genetically modified models of human diseases by introducing specific mutations into their genomes.

Some commonly used inbred strains of rats include the Wistar Kyoto (WKY), Sprague-Dawley (SD), and Fischer 344 (F344) rat strains. Each strain has its own unique genetic characteristics, making them suitable for different types of research.

Protein kinases are a group of enzymes that play a crucial role in many cellular processes by adding phosphate groups to other proteins, a process known as phosphorylation. This modification can activate or deactivate the target protein's function, thereby regulating various signaling pathways within the cell. Protein kinases are essential for numerous biological functions, including metabolism, signal transduction, cell cycle progression, and apoptosis (programmed cell death). Abnormal regulation of protein kinases has been implicated in several diseases, such as cancer, diabetes, and neurological disorders.

Molecular weight, also known as molecular mass, is the mass of a molecule. It is expressed in units of atomic mass units (amu) or daltons (Da). Molecular weight is calculated by adding up the atomic weights of each atom in a molecule. It is a useful property in chemistry and biology, as it can be used to determine the concentration of a substance in a solution, or to calculate the amount of a substance that will react with another in a chemical reaction.

Calmodulin is a small, ubiquitous calcium-binding protein that plays a critical role in various intracellular signaling pathways. It functions as a calcium sensor, binding to and regulating the activity of numerous target proteins upon calcium ion (Ca^2+^) binding. Calmodulin is expressed in all eukaryotic cells and participates in many cellular processes, including muscle contraction, neurotransmitter release, gene expression, metabolism, and cell cycle progression.

The protein contains four EF-hand motifs that can bind Ca^2+^ ions. Upon calcium binding, conformational changes occur in the calmodulin structure, exposing hydrophobic surfaces that facilitate its interaction with target proteins. Calmodulin's targets include enzymes (such as protein kinases and phosphatases), ion channels, transporters, and cytoskeletal components. By modulating the activity of these proteins, calmodulin helps regulate essential cellular functions in response to changes in intracellular Ca^2+^ concentrations.

Calmodulin's molecular weight is approximately 17 kDa, and it consists of a single polypeptide chain with 148-150 amino acid residues. The protein can be found in both the cytoplasm and the nucleus of cells. In addition to its role as a calcium sensor, calmodulin has been implicated in various pathological conditions, including cancer, neurodegenerative diseases, and cardiovascular disorders.

"Schizophyllum" is not a term that has a medical definition on its own. However, it is the name of a genus of fungi that are commonly found in temperate and tropical regions worldwide. The most common and well-known species in this genus is Schizophyllum commune, which is known to cause a rare and mild form of respiratory infection in humans called pulmonary schizophyllosis.

Pulmonary schizophyllosis is caused by inhaling the spores of S. commune, which can lead to allergic reactions or, more rarely, invasive fungal infections in people with weakened immune systems. Symptoms of this condition may include coughing, chest pain, fever, and difficulty breathing.

It's worth noting that pulmonary schizophyllosis is a very rare disease, and most people who come into contact with S. commune fungi do not develop any symptoms or health problems. Nonetheless, it is important for medical professionals to be aware of this potential infection source in immunocompromised patients who present with respiratory symptoms.

"Thermoanaerobacter" is a genus of bacteria that are thermophilic (grow optimally at higher temperatures), anaerobic (do not require oxygen for growth), and straight or slightly curved rods in shape. They are capable of fermenting various sugars, organic acids, and alcohols to produce energy, with the formation of end products such as hydrogen, carbon dioxide, and acetic acid. These bacteria can be found in environments like hot springs, compost piles, and oil wells. It's important to note that individual species within this genus may have additional specific characteristics or requirements for growth.

Glycogenolysis is the biochemical process by which glycogen, a polymer of glucose, is broken down into its constituent glucose molecules. This process occurs primarily in the liver and muscles and is critical for maintaining normal blood glucose levels between meals and during periods of increased physical activity.

Glycogenolysis is initiated by the enzyme glycogen phosphorylase, which cleaves off individual glucose molecules from the end of a glycogen branch, resulting in the formation of glucose-1-phosphate. This compound is then converted to glucose-6-phosphate by the enzyme phosphoglucomutase.

Glucose-6-phosphate can be further metabolized through several pathways, including glycolysis or the pentose phosphate pathway, depending on the energy needs of the cell. In the liver, glucose-6-phosphatase can remove the phosphate group from glucose-6-phosphate to produce free glucose, which is released into the bloodstream and transported to other tissues for use as an energy source.

Overall, glycogenolysis plays a crucial role in maintaining normal blood glucose levels and providing energy to cells during periods of increased demand.

The Glycogen Debranching Enzyme System, also known as glycogen debranching enzyme or Amy-1, is a crucial enzyme complex in human biochemistry. It plays an essential role in the metabolism of glycogen, which is a large, branched polymer of glucose that serves as the primary form of energy storage in animals and fungi.

The Glycogen Debranching Enzyme System consists of two enzymatic activities: a transferase and an exo-glucosidase. The transferase activity transfers a segment of a branched glucose chain to another part of the same or another glycogen molecule, while the exo-glucosidase activity cleaves the remaining single glucose units from the outer branches of the glycogen molecule.

This enzyme system is responsible for removing the branched structures of glycogen, allowing the linear chains to be further degraded by other enzymes into glucose molecules that can be used for energy production or stored for later use. Defects in this enzyme complex can lead to several genetic disorders, such as Glycogen Storage Disease Type III (Cori's disease) and Type IV (Andersen's disease), which are characterized by the accumulation of abnormal glycogen molecules in various tissues.

Phosphorylation is the process of adding a phosphate group (a molecule consisting of one phosphorus atom and four oxygen atoms) to a protein or other organic molecule, which is usually done by enzymes called kinases. This post-translational modification can change the function, localization, or activity of the target molecule, playing a crucial role in various cellular processes such as signal transduction, metabolism, and regulation of gene expression. Phosphorylation is reversible, and the removal of the phosphate group is facilitated by enzymes called phosphatases.

Catalysis is the process of increasing the rate of a chemical reaction by adding a substance known as a catalyst, which remains unchanged at the end of the reaction. A catalyst lowers the activation energy required for the reaction to occur, thereby allowing the reaction to proceed more quickly and efficiently. This can be particularly important in biological systems, where enzymes act as catalysts to speed up metabolic reactions that are essential for life.

Adenosine Deaminase (ADA) is an enzyme that plays a crucial role in the immune system by helping to regulate the levels of certain chemicals called purines within cells. Specifically, ADA helps to break down adenosine, a type of purine, into another compound called inosine. This enzyme is found in all tissues of the body, but it is especially active in the immune system's white blood cells, where it helps to support their growth, development, and function.

ADA deficiency is a rare genetic disorder that can lead to severe combined immunodeficiency (SCID), a condition in which babies are born with little or no functional immune system. This makes them extremely vulnerable to infections, which can be life-threatening. ADA deficiency can be treated with enzyme replacement therapy, bone marrow transplantation, or gene therapy.

Methylthioinosine is not a widely recognized or used term in medicine, and it does not have a specific medical definition. It is a chemical compound that is formed by the addition of a methylthio group (-CH3S-) to the nucleoside inosine. Inosine is a purine nucleoside that is formed from the deamination of adenosine.

Methylthioinosine has been studied in some laboratory experiments, but it is not commonly used in clinical medicine or treatment. Therefore, it is not a term that most medical professionals would be familiar with.

A nucleoside is a biochemical molecule that consists of a pentose sugar (a type of simple sugar with five carbon atoms) covalently linked to a nitrogenous base. The nitrogenous base can be one of several types, including adenine, guanine, cytosine, thymine, or uracil. Nucleosides are important components of nucleic acids, such as DNA and RNA, which are the genetic materials found in cells. They play a crucial role in various biological processes, including cell division, protein synthesis, and gene expression.

Sugar alcohols, also known as polyols, are carbohydrates that are chemically similar to sugar but have a different molecular structure. They occur naturally in some fruits and vegetables, but most sugar alcohols used in food products are manufactured.

The chemical structure of sugar alcohols contains a hydroxyl group (-OH) instead of a hydrogen and a ketone or aldehyde group, which makes them less sweet than sugar and have fewer calories. They are not completely absorbed by the body, so they do not cause a rapid increase in blood glucose levels, making them a popular sweetener for people with diabetes.

Common sugar alcohols used in food products include xylitol, sorbitol, mannitol, erythritol, and maltitol. They are often used as sweeteners in sugar-free and low-sugar foods such as candy, chewing gum, baked goods, and beverages.

However, consuming large amounts of sugar alcohols can cause digestive symptoms such as bloating, gas, and diarrhea, due to their partial absorption in the gut. Therefore, it is recommended to consume them in moderation.

Inborn errors of purine-pyrimidine metabolism refer to genetic disorders that result in dysfunctional enzymes involved in the metabolic pathways of purines and pyrimidines. These are essential components of nucleotides, which in turn are building blocks of DNA and RNA.

Inherited as autosomal recessive or X-linked recessive traits, these disorders can lead to an accumulation of toxic metabolites, a deficiency of necessary compounds, or both. Clinical features vary widely depending on the specific enzyme defect but may include neurologic symptoms, kidney problems, gout, and/or immunodeficiency.

Examples of such disorders include Lesch-Nyhan syndrome (deficiency of hypoxanthine-guanine phosphoribosyltransferase), adenosine deaminase deficiency (leading to severe combined immunodeficiency), and orotic aciduria (due to defects in pyrimidine metabolism). Early diagnosis and management are crucial to improve outcomes.

Adenosine Triphosphate (ATP) is a high-energy molecule that stores and transports energy within cells. It is the main source of energy for most cellular processes, including muscle contraction, nerve impulse transmission, and protein synthesis. ATP is composed of a base (adenine), a sugar (ribose), and three phosphate groups. The bonds between these phosphate groups contain a significant amount of energy, which can be released when the bond between the second and third phosphate group is broken, resulting in the formation of adenosine diphosphate (ADP) and inorganic phosphate. This process is known as hydrolysis and can be catalyzed by various enzymes to drive a wide range of cellular functions. ATP can also be regenerated from ADP through various metabolic pathways, such as oxidative phosphorylation or substrate-level phosphorylation, allowing for the continuous supply of energy to cells.

Epinephrine, also known as adrenaline, is a hormone and a neurotransmitter that is produced in the body. It is released by the adrenal glands in response to stress or excitement, and it prepares the body for the "fight or flight" response. Epinephrine works by binding to specific receptors in the body, which causes a variety of physiological effects, including increased heart rate and blood pressure, improved muscle strength and alertness, and narrowing of the blood vessels in the skin and intestines. It is also used as a medication to treat various medical conditions, such as anaphylaxis (a severe allergic reaction), cardiac arrest, and low blood pressure.

Pyridoxal is a form of vitamin B6, specifically the alcohol form of pyridoxine. It is a cofactor for many enzymes involved in protein metabolism and synthesis of neurotransmitters. Pyridoxal can be converted to its active form, pyridoxal 5'-phosphate (PLP), which serves as a coenzyme in various biochemical reactions, including transamination, decarboxylation, and racemization/elimination reactions. Deficiency in vitamin B6 can lead to neurological disorders and impaired synthesis of amino acids and neurotransmitters.

Protein conformation refers to the specific three-dimensional shape that a protein molecule assumes due to the spatial arrangement of its constituent amino acid residues and their associated chemical groups. This complex structure is determined by several factors, including covalent bonds (disulfide bridges), hydrogen bonds, van der Waals forces, and ionic bonds, which help stabilize the protein's unique conformation.

Protein conformations can be broadly classified into two categories: primary, secondary, tertiary, and quaternary structures. The primary structure represents the linear sequence of amino acids in a polypeptide chain. The secondary structure arises from local interactions between adjacent amino acid residues, leading to the formation of recurring motifs such as α-helices and β-sheets. Tertiary structure refers to the overall three-dimensional folding pattern of a single polypeptide chain, while quaternary structure describes the spatial arrangement of multiple folded polypeptide chains (subunits) that interact to form a functional protein complex.

Understanding protein conformation is crucial for elucidating protein function, as the specific three-dimensional shape of a protein directly influences its ability to interact with other molecules, such as ligands, nucleic acids, or other proteins. Any alterations in protein conformation due to genetic mutations, environmental factors, or chemical modifications can lead to loss of function, misfolding, aggregation, and disease states like neurodegenerative disorders and cancer.

Uridine is a nucleoside that consists of a pyrimidine base (uracil) linked to a pentose sugar (ribose). It is a component of RNA, where it pairs with adenine. Uridine can also be found in various foods such as beer, broccoli, yeast, and meat. In the body, uridine can be synthesized from orotate or from the breakdown of RNA. It has several functions, including acting as a building block for RNA, contributing to energy metabolism, and regulating cell growth and differentiation. Uridine is also available as a dietary supplement and has been studied for its potential benefits in various health conditions.

Leuconostoc is a genus of gram-positive, facultatively anaerobic bacteria that belong to the family Leuconostocaceae. These bacteria are non-motile, non-spore forming, and occur as pairs or chains. They are catalase-negative and reduce nitrate to nitrite.

Leuconostoc species are commonly found in nature, particularly in plants, dairy products, and fermented foods. They play a significant role in the food industry, where they are used in the production of various fermented foods such as sauerkraut, pickles, and certain cheeses.

In clinical settings, Leuconostoc species can sometimes be associated with healthcare-associated infections, particularly in patients who have underlying medical conditions or who are immunocompromised. They can cause bacteremia, endocarditis, and device-related infections. However, these infections are relatively rare, and the majority of Leuconostoc species are considered to be non-pathogenic.

Pyrimidine nucleosides are organic compounds that consist of a pyrimidine base (a heterocyclic aromatic ring containing two nitrogen atoms and four carbon atoms) linked to a sugar molecule, specifically ribose or deoxyribose, via a β-glycosidic bond. The pyrimidine bases found in nucleosides can be cytosine (C), thymine (T), or uracil (U). When the sugar component is ribose, it is called a pyrimidine nucleoside, and when it is linked to deoxyribose, it is referred to as a deoxy-pyrimidine nucleoside. These molecules play crucial roles in various biological processes, particularly in the structure and function of nucleic acids such as DNA and RNA.

Uridine Diphosphate Glucose (UDP-glucose) is a nucleotide sugar that plays a crucial role in the synthesis and metabolism of carbohydrates in the body. It is formed from uridine triphosphate (UTP) and glucose-1-phosphate through the action of the enzyme UDP-glucose pyrophosphorylase.

UDP-glucose serves as a key intermediate in various biochemical pathways, including glycogen synthesis, where it donates glucose molecules to form glycogen, a large polymeric storage form of glucose found primarily in the liver and muscles. It is also involved in the biosynthesis of other carbohydrate-containing compounds such as proteoglycans and glycolipids.

Moreover, UDP-glucose is an essential substrate for the enzyme glucosyltransferase, which is responsible for adding glucose molecules to various acceptor molecules during the process of glycosylation. This post-translational modification is critical for the proper folding and functioning of many proteins.

Overall, UDP-glucose is a vital metabolic intermediate that plays a central role in carbohydrate metabolism and protein function.

Calcium is an essential mineral that is vital for various physiological processes in the human body. The medical definition of calcium is as follows:

Calcium (Ca2+) is a crucial cation and the most abundant mineral in the human body, with approximately 99% of it found in bones and teeth. It plays a vital role in maintaining structural integrity, nerve impulse transmission, muscle contraction, hormonal secretion, blood coagulation, and enzyme activation.

Calcium homeostasis is tightly regulated through the interplay of several hormones, including parathyroid hormone (PTH), calcitonin, and vitamin D. Dietary calcium intake, absorption, and excretion are also critical factors in maintaining optimal calcium levels in the body.

Hypocalcemia refers to low serum calcium levels, while hypercalcemia indicates high serum calcium levels. Both conditions can have detrimental effects on various organ systems and require medical intervention to correct.

Magnesium is an essential mineral that plays a crucial role in various biological processes in the human body. It is the fourth most abundant cation in the body and is involved in over 300 enzymatic reactions, including protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. Magnesium also contributes to the structural development of bones and teeth.

In medical terms, magnesium deficiency can lead to several health issues, such as muscle cramps, weakness, heart arrhythmias, and seizures. On the other hand, excessive magnesium levels can cause symptoms like diarrhea, nausea, and muscle weakness. Magnesium supplements or magnesium-rich foods are often recommended to maintain optimal magnesium levels in the body.

Some common dietary sources of magnesium include leafy green vegetables, nuts, seeds, legumes, whole grains, and dairy products. Magnesium is also available in various forms as a dietary supplement, including magnesium oxide, magnesium citrate, magnesium chloride, and magnesium glycinate.

Allosteric regulation is a process that describes the way in which the binding of a molecule (known as a ligand) to an enzyme or protein at one site affects the ability of another molecule to bind to a different site on the same enzyme or protein. This interaction can either enhance (positive allosteric regulation) or inhibit (negative allosteric regulation) the activity of the enzyme or protein, depending on the nature of the ligand and its effect on the shape and/or conformation of the enzyme or protein.

In an allosteric regulatory system, the binding of the first molecule to the enzyme or protein causes a conformational change in the protein structure that alters the affinity of the second site for its ligand. This can result in changes in the activity of the enzyme or protein, allowing for fine-tuning of biochemical pathways and regulatory processes within cells.

Allosteric regulation is a fundamental mechanism in many biological systems, including metabolic pathways, signal transduction cascades, and gene expression networks. Understanding allosteric regulation can provide valuable insights into the mechanisms underlying various physiological and pathological processes, and can inform the development of novel therapeutic strategies for the treatment of disease.

Purines are heterocyclic aromatic organic compounds that consist of a pyrimidine ring fused to an imidazole ring. They are fundamental components of nucleotides, which are the building blocks of DNA and RNA. In the body, purines can be synthesized endogenously or obtained through dietary sources such as meat, seafood, and certain vegetables.

Once purines are metabolized, they are broken down into uric acid, which is excreted by the kidneys. Elevated levels of uric acid in the body can lead to the formation of uric acid crystals, resulting in conditions such as gout or kidney stones. Therefore, maintaining a balanced intake of purine-rich foods and ensuring proper kidney function are essential for overall health.

"Micrococcus" is a genus of Gram-positive, catalase-positive, aerobic bacteria that are commonly found in pairs or tetrads. They are typically spherical in shape and range from 0.5 to 3 micrometers in diameter. Micrococci are ubiquitous in nature and can be found on the skin and mucous membranes of humans and animals, as well as in soil, water, and air.

Micrococci are generally considered to be harmless commensals, but they have been associated with a variety of infections in immunocompromised individuals, including bacteremia, endocarditis, and pneumonia. They can also cause contamination of medical equipment and supplies, leading to nosocomial infections.

It's worth noting that the taxonomy of this genus has undergone significant revisions in recent years, and many species previously classified as Micrococcus have been reassigned to other genera. As a result, the medical significance of this genus is somewhat limited.

Pentose phosphates are monosaccharides that contain five carbon atoms and one phosphate group. They play a crucial role in various metabolic pathways, including the pentose phosphate pathway (PPP), which is a major source of NADPH and ribose-5-phosphate for the synthesis of nucleotides.

The pentose phosphate pathway involves two main phases: the oxidative phase and the non-oxidative phase. In the oxidative phase, glucose-6-phosphate is converted to ribulose-5-phosphate, producing NADPH and CO2 as byproducts. Ribulose-5-phosphate can then be further metabolized in the non-oxidative phase to produce other pentose phosphates or converted back to glucose-6-phosphate through a series of reactions.

Pentose phosphates are also important intermediates in the synthesis of nucleotides, coenzymes, and other metabolites. Abnormalities in pentose phosphate pathway enzymes can lead to various metabolic disorders, such as defects in erythrocyte function and increased susceptibility to oxidative stress.

Protein binding, in the context of medical and biological sciences, refers to the interaction between a protein and another molecule (known as the ligand) that results in a stable complex. This process is often reversible and can be influenced by various factors such as pH, temperature, and concentration of the involved molecules.

In clinical chemistry, protein binding is particularly important when it comes to drugs, as many of them bind to proteins (especially albumin) in the bloodstream. The degree of protein binding can affect a drug's distribution, metabolism, and excretion, which in turn influence its therapeutic effectiveness and potential side effects.

Protein-bound drugs may be less available for interaction with their target tissues, as only the unbound or "free" fraction of the drug is active. Therefore, understanding protein binding can help optimize dosing regimens and minimize adverse reactions.

Trifluridine is an antiviral medication that is primarily used to treat herpetic keratitis, which is a viral infection of the eye caused by the herpes simplex virus. It works by interfering with the replication of the virus's DNA, thereby preventing it from multiplying and causing further damage to the eye.

Trifluridine is available as an ophthalmic solution (eye drops) and is typically applied directly to the affected eye every 2 hours while awake, for a total of 9 doses per day. The treatment period usually lasts for up to 14 days or until the symptoms have resolved.

It's important to note that trifluridine is not used to treat other forms of herpes simplex infections, such as cold sores or genital herpes, and should only be used under the supervision of a healthcare professional.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Manganese is not a medical condition, but it's an essential trace element that is vital for human health. Here is the medical definition of Manganese:

Manganese (Mn) is a trace mineral that is present in tiny amounts in the body. It is found mainly in bones, the liver, kidneys, and pancreas. Manganese helps the body form connective tissue, bones, blood clotting factors, and sex hormones. It also plays a role in fat and carbohydrate metabolism, calcium absorption, and blood sugar regulation. Manganese is also necessary for normal brain and nerve function.

The recommended dietary allowance (RDA) for manganese is 2.3 mg per day for adult men and 1.8 mg per day for adult women. Good food sources of manganese include nuts, seeds, legumes, whole grains, green leafy vegetables, and tea.

In some cases, exposure to high levels of manganese can cause neurological symptoms similar to Parkinson's disease, a condition known as manganism. However, this is rare and usually occurs in people who are occupationally exposed to manganese dust or fumes, such as welders.

Inosine monophosphate (IMP) is a nucleotide that plays a crucial role in the metabolic pathways of energy production and purine synthesis in cells. It is an ester of the nucleoside inosine and phosphoric acid. IMP is an important intermediate in the conversion of adenosine monophosphate (AMP) to guanosine monophosphate (GMP) in the purine nucleotide cycle, which is critical for maintaining the balance of purine nucleotides in the body. Additionally, IMP can be converted back to AMP through the action of the enzyme adenylosuccinate lyase. IMP has been studied for its potential therapeutic benefits in various medical conditions, including neurodegenerative disorders and ischemia-reperfusion injury.

X-ray crystallography is a technique used in structural biology to determine the three-dimensional arrangement of atoms in a crystal lattice. In this method, a beam of X-rays is directed at a crystal and diffracts, or spreads out, into a pattern of spots called reflections. The intensity and angle of each reflection are measured and used to create an electron density map, which reveals the position and type of atoms in the crystal. This information can be used to determine the molecular structure of a compound, including its shape, size, and chemical bonds. X-ray crystallography is a powerful tool for understanding the structure and function of biological macromolecules such as proteins and nucleic acids.

Nucleoside deaminases are a group of enzymes that catalyze the removal of an amino group (-NH2) from nucleosides, converting them to nucleosides with a modified base. This modification process is called deamination. Specifically, these enzymes convert cytidine and adenosine to uridine and inosine, respectively. Nucleoside deaminases play crucial roles in various biological processes, including the regulation of gene expression, immune response, and nucleic acid metabolism. Some nucleoside deaminases are also involved in the development of certain diseases and are considered as targets for drug design and discovery.

Pyrimidinones are a class of heterocyclic organic compounds that contain a pyrimidine ring fused with a ketone group. The basic structure of a pyrimidinone consists of two nitrogen atoms and four carbon atoms in a six-membered ring, with a carbonyl (C=O) group attached to one of the carbon atoms.

In a medical context, pyrimidinones are important because many naturally occurring and synthetic compounds that contain this structure have been found to have biological activity. For example, some pyrimidinones have antiviral, antibacterial, or anticancer properties, making them useful in the development of new drugs for various medical conditions.

One well-known drug that contains a pyrimidinone ring is the antiviral medication Ribavirin, which is used to treat hepatitis C and certain viral hemorrhagic fevers. Other pyrimidinones are being studied for their potential therapeutic benefits in areas such as cancer therapy, neuroprotection, and inflammation.

Gel chromatography is a type of liquid chromatography that separates molecules based on their size or molecular weight. It uses a stationary phase that consists of a gel matrix made up of cross-linked polymers, such as dextran, agarose, or polyacrylamide. The gel matrix contains pores of various sizes, which allow smaller molecules to penetrate deeper into the matrix while larger molecules are excluded.

In gel chromatography, a mixture of molecules is loaded onto the top of the gel column and eluted with a solvent that moves down the column by gravity or pressure. As the sample components move down the column, they interact with the gel matrix and get separated based on their size. Smaller molecules can enter the pores of the gel and take longer to elute, while larger molecules are excluded from the pores and elute more quickly.

Gel chromatography is commonly used to separate and purify proteins, nucleic acids, and other biomolecules based on their size and molecular weight. It is also used in the analysis of polymers, colloids, and other materials with a wide range of applications in chemistry, biology, and medicine.

Molecular models are three-dimensional representations of molecular structures that are used in the field of molecular biology and chemistry to visualize and understand the spatial arrangement of atoms and bonds within a molecule. These models can be physical or computer-generated and allow researchers to study the shape, size, and behavior of molecules, which is crucial for understanding their function and interactions with other molecules.

Physical molecular models are often made up of balls (representing atoms) connected by rods or sticks (representing bonds). These models can be constructed manually using materials such as plastic or wooden balls and rods, or they can be created using 3D printing technology.

Computer-generated molecular models, on the other hand, are created using specialized software that allows researchers to visualize and manipulate molecular structures in three dimensions. These models can be used to simulate molecular interactions, predict molecular behavior, and design new drugs or chemicals with specific properties. Overall, molecular models play a critical role in advancing our understanding of molecular structures and their functions.

An allosteric site is a distinct and separate binding site on a protein (usually an enzyme) other than the active site where the substrate binds. The binding of a molecule (known as an allosteric modulator or effector) to this site can cause a conformational change in the protein's structure, which in turn affects its activity, either by enhancing (allosteric activation) or inhibiting (allosteric inhibition) its function. This allosteric regulation allows for complex control mechanisms in biological systems and is crucial for many cellular processes.

Enzyme inhibitors are substances that bind to an enzyme and decrease its activity, preventing it from catalyzing a chemical reaction in the body. They can work by several mechanisms, including blocking the active site where the substrate binds, or binding to another site on the enzyme to change its shape and prevent substrate binding. Enzyme inhibitors are often used as drugs to treat various medical conditions, such as high blood pressure, abnormal heart rhythms, and bacterial infections. They can also be found naturally in some foods and plants, and can be used in research to understand enzyme function and regulation.

Isoenzymes, also known as isoforms, are multiple forms of an enzyme that catalyze the same chemical reaction but differ in their amino acid sequence, structure, and/or kinetic properties. They are encoded by different genes or alternative splicing of the same gene. Isoenzymes can be found in various tissues and organs, and they play a crucial role in biological processes such as metabolism, detoxification, and cell signaling. Measurement of isoenzyme levels in body fluids (such as blood) can provide valuable diagnostic information for certain medical conditions, including tissue damage, inflammation, and various diseases.

Uridine kinase is an enzyme that phosphorylates the pyrimidine nucleoside uridine to produce uridine monophosphate (UMP). This reaction plays a crucial role in the salvage pathway of pyrimidine nucleotide synthesis, which recycles nucleosides generated from the degradation of RNA.

The human genome encodes two isoforms of uridine kinase, UCK1 and UCK2, which share a high degree of sequence similarity but have distinct tissue expression patterns and subcellular localization. UCK1 is primarily expressed in the liver and kidney, while UCK2 is more widely expressed in various tissues.

Uridine kinase activity has been implicated in several physiological processes, including the regulation of intracellular nucleotide pools, the biosynthesis of glycosaminoglycans and proteoglycans, and the modulation of antiviral responses. Dysregulation of uridine kinase activity has been associated with various pathological conditions, such as cancer, viral infections, and neurological disorders.

A prodrug is a pharmacologically inactive substance that, once administered, is metabolized into a drug that is active. Prodrugs are designed to improve the bioavailability or delivery of a drug, to minimize adverse effects, or to target the drug to specific sites in the body. The conversion of a prodrug to its active form typically occurs through enzymatic reactions in the liver or other tissues.

Prodrugs can offer several advantages over traditional drugs, including:

* Improved absorption: Some drugs have poor bioavailability due to their chemical properties, which make them difficult to absorb from the gastrointestinal tract. Prodrugs can be designed with improved absorption characteristics, allowing for more efficient delivery of the active drug to the body.
* Reduced toxicity: By masking the active drug's chemical structure, prodrugs can reduce its interactions with sensitive tissues and organs, thereby minimizing adverse effects.
* Targeted delivery: Prodrugs can be designed to selectively release the active drug in specific areas of the body, such as tumors or sites of infection, allowing for more precise and effective therapy.

Examples of prodrugs include:

* Aspirin (acetylsalicylic acid), which is metabolized to salicylic acid in the liver.
* Enalapril, an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and heart failure, which is metabolized to enalaprilat in the liver.
* Codeine, an opioid analgesic, which is metabolized to morphine in the liver by the enzyme CYP2D6.

It's important to note that not all prodrugs are successful, and some may even have unintended consequences. For example, if a patient has a genetic variation that affects the activity of the enzyme responsible for converting the prodrug to its active form, the drug may not be effective or may produce adverse effects. Therefore, it's essential to consider individual genetic factors when prescribing prodrugs.

Deoxyguanine nucleotides are chemical compounds that are the building blocks of DNA, one of the fundamental molecules of life. Specifically, deoxyguanine nucleotides contain a sugar molecule called deoxyribose, a phosphate group, and the nitrogenous base guanine.

Guanine is one of the four nitrogenous bases found in DNA, along with adenine, thymine, and cytosine. In DNA, guanine always pairs with cytosine through hydrogen bonding, forming a stable base pair that is crucial for maintaining the structure and integrity of the genetic code.

Deoxyguanine nucleotides are synthesized in cells during the process of DNA replication, which occurs prior to cell division. During replication, the double helix structure of DNA is unwound, and each strand serves as a template for the synthesis of a new complementary strand. Deoxyguanine nucleotides are added to the growing chain of nucleotides by an enzyme called DNA polymerase, which catalyzes the formation of a phosphodiester bond between the deoxyribose sugar of one nucleotide and the phosphate group of the next.

Abnormalities in the synthesis or metabolism of deoxyguanine nucleotides can lead to genetic disorders and cancer. For example, mutations in genes that encode enzymes involved in the synthesis of deoxyguanine nucleotides have been linked to inherited diseases such as xeroderma pigmentosum and Bloom syndrome, which are characterized by increased sensitivity to sunlight and a predisposition to cancer. Additionally, defects in the repair of damaged deoxyguanine nucleotides can lead to the accumulation of mutations and contribute to the development of cancer.

Nucleotidyltransferases are a class of enzymes that catalyze the transfer of nucleotides to an acceptor molecule, such as RNA or DNA. These enzymes play crucial roles in various biological processes, including DNA replication, repair, and recombination, as well as RNA synthesis and modification.

The reaction catalyzed by nucleotidyltransferases typically involves the donation of a nucleoside triphosphate (NTP) to an acceptor molecule, resulting in the formation of a phosphodiester bond between the nucleotides. The reaction can be represented as follows:

NTP + acceptor → NMP + pyrophosphate

where NTP is the nucleoside triphosphate donor and NMP is the nucleoside monophosphate product.

There are several subclasses of nucleotidyltransferases, including polymerases, ligases, and terminases. These enzymes have distinct functions and substrate specificities, but all share the ability to transfer nucleotides to an acceptor molecule.

Examples of nucleotidyltransferases include DNA polymerase, RNA polymerase, reverse transcriptase, telomerase, and ligase. These enzymes are essential for maintaining genome stability and function, and their dysregulation has been implicated in various diseases, including cancer and neurodegenerative disorders.

A catalytic domain is a portion or region within a protein that contains the active site, where the chemical reactions necessary for the protein's function are carried out. This domain is responsible for the catalysis of biological reactions, hence the name "catalytic domain." The catalytic domain is often composed of specific amino acid residues that come together to form the active site, creating a unique three-dimensional structure that enables the protein to perform its specific function.

In enzymes, for example, the catalytic domain contains the residues that bind and convert substrates into products through chemical reactions. In receptors, the catalytic domain may be involved in signal transduction or other regulatory functions. Understanding the structure and function of catalytic domains is crucial to understanding the mechanisms of protein function and can provide valuable insights for drug design and therapeutic interventions.

"Solanum tuberosum" is the scientific name for a plant species that is commonly known as the potato. According to medical and botanical definitions, Solanum tuberosum refers to the starchy, edible tubers that grow underground from this plant. Potatoes are native to the Andes region of South America and are now grown worldwide. They are an important food source for many people and are used in a variety of culinary applications.

Potatoes contain several essential nutrients, including carbohydrates, fiber, protein, vitamin C, and some B vitamins. However, they can also be high in calories, especially when prepared with added fats like butter or oil. Additionally, potatoes are often consumed in forms that are less healthy, such as French fries and potato chips, which can contribute to weight gain and other health problems if consumed excessively.

In a medical context, potatoes may also be discussed in relation to food allergies or intolerances. While uncommon, some people may have adverse reactions to potatoes, including skin rashes, digestive symptoms, or difficulty breathing. These reactions are typically caused by an immune response to proteins found in the potato plant, rather than the tubers themselves.

Fluorouracil is a antineoplastic medication, which means it is used to treat cancer. It is a type of chemotherapy drug known as an antimetabolite. Fluorouracil works by interfering with the growth of cancer cells and ultimately killing them. It is often used to treat colon, esophageal, stomach, and breast cancers, as well as skin conditions such as actinic keratosis and superficial basal cell carcinoma. Fluorouracil may be given by injection or applied directly to the skin in the form of a cream.

It is important to note that fluorouracil can have serious side effects, including suppression of bone marrow function, mouth sores, stomach and intestinal ulcers, and nerve damage. It should only be used under the close supervision of a healthcare professional.

Fluorides are ionic compounds that contain the fluoride anion (F-). In the context of dental and public health, fluorides are commonly used in preventive measures to help reduce tooth decay. They can be found in various forms such as sodium fluoride, stannous fluoride, and calcium fluoride. When these compounds come into contact with saliva, they release fluoride ions that can be absorbed by tooth enamel. This process helps to strengthen the enamel and make it more resistant to acid attacks caused by bacteria in the mouth, which can lead to dental caries or cavities. Fluorides can be topically applied through products like toothpaste, mouth rinses, and fluoride varnishes, or systemically ingested through fluoridated water, salt, or supplements.

Vasopressin, also known as antidiuretic hormone (ADH), is a hormone that helps regulate water balance in the body. It is produced by the hypothalamus and stored in the posterior pituitary gland. When the body is dehydrated or experiencing low blood pressure, vasopressin is released into the bloodstream, where it causes the kidneys to decrease the amount of urine they produce and helps to constrict blood vessels, thereby increasing blood pressure. This helps to maintain adequate fluid volume in the body and ensure that vital organs receive an adequate supply of oxygen-rich blood. In addition to its role in water balance and blood pressure regulation, vasopressin also plays a role in social behaviors such as pair bonding and trust.

Deoxyribonucleosides are chemical compounds that constitute the basic building blocks of DNA, one of the two nucleic acids found in cells. They consist of a sugar molecule called deoxyribose, a nitrogenous base (either adenine, guanine, cytosine, or thymine), and a phosphate group.

The nitrogenous base is attached to the 1' carbon atom of the deoxyribose sugar, forming a glycosidic bond. The phosphate group is linked to the 5' carbon atom of the deoxyribose sugar through an ester linkage, creating a phosphodiester bond with another deoxyribonucleoside.

When multiple deoxyribonucleosides are joined together through their phosphate groups, they form a polynucleotide chain, which is the backbone of DNA. The sequence of nitrogenous bases along this chain encodes genetic information that determines the characteristics and functions of living organisms.

Deoxyribonucleosides play a crucial role in various biological processes, including DNA replication, repair, and transcription. They are also used as therapeutic agents for the treatment of certain genetic disorders and cancer.

Caffeine is a central nervous system stimulant that occurs naturally in the leaves, seeds, or fruits of some plants. It can also be produced artificially and added to various products, such as food, drinks, and medications. Caffeine has a number of effects on the body, including increasing alertness, improving mood, and boosting energy levels.

In small doses, caffeine is generally considered safe for most people. However, consuming large amounts of caffeine can lead to negative side effects, such as restlessness, insomnia, rapid heart rate, and increased blood pressure. It is also possible to become dependent on caffeine, and withdrawal symptoms can occur if consumption is suddenly stopped.

Caffeine is found in a variety of products, including coffee, tea, chocolate, energy drinks, and some medications. The amount of caffeine in these products can vary widely, so it is important to pay attention to serving sizes and labels to avoid consuming too much.

A pentose is a monosaccharide (simple sugar) that contains five carbon atoms. The name "pentose" comes from the Greek word "pente," meaning five, and "ose," meaning sugar. Pentoses play important roles in various biological processes, such as serving as building blocks for nucleic acids (DNA and RNA) and other biomolecules.

Some common pentoses include:

1. D-Ribose - A naturally occurring pentose found in ribonucleic acid (RNA), certain coenzymes, and energy-carrying molecules like adenosine triphosphate (ATP).
2. D-Deoxyribose - A pentose that lacks a hydroxyl (-OH) group on the 2' carbon atom, making it a key component of deoxyribonucleic acid (DNA).
3. Xylose - A naturally occurring pentose found in various plants and woody materials; it is used as a sweetener and food additive.
4. Arabinose - Another plant-derived pentose, arabinose can be found in various fruits, vegetables, and grains. It has potential applications in the production of biofuels and other bioproducts.
5. Lyxose - A less common pentose that can be found in some polysaccharides and glycoproteins.

Pentoses are typically less sweet than hexoses (six-carbon sugars) like glucose or fructose, but they still contribute to the overall sweetness of many foods and beverages.

An amide is a functional group or a compound that contains a carbonyl group (a double-bonded carbon atom) and a nitrogen atom. The nitrogen atom is connected to the carbonyl carbon atom by a single bond, and it also has a lone pair of electrons. Amides are commonly found in proteins and peptides, where they form amide bonds (also known as peptide bonds) between individual amino acids.

The general structure of an amide is R-CO-NHR', where R and R' can be alkyl or aryl groups. Amides can be classified into several types based on the nature of R and R' substituents:

* Primary amides: R-CO-NH2
* Secondary amides: R-CO-NHR'
* Tertiary amides: R-CO-NR''R'''

Amides have several important chemical properties. They are generally stable and resistant to hydrolysis under neutral or basic conditions, but they can be hydrolyzed under acidic conditions or with strong bases. Amides also exhibit a characteristic infrared absorption band around 1650 cm-1 due to the carbonyl stretching vibration.

In addition to their prevalence in proteins and peptides, amides are also found in many natural and synthetic compounds, including pharmaceuticals, dyes, and polymers. They have a wide range of applications in chemistry, biology, and materials science.

Polynucleotide adenylyltransferase is not a medical term per se, but rather a biological term used to describe an enzyme that catalyzes the addition of adenine residues to the 3'-hydroxyl end of polynucleotides. In other words, these enzymes transfer AMP (adenosine monophosphate) molecules to the ends of DNA or RNA strands, creating a chain of adenine nucleotides.

One of the most well-known examples of this class of enzyme is terminal transferase, which is often used in research settings for various molecular biology techniques such as adding homopolymeric tails to DNA molecules. It's worth noting that while these enzymes have important applications in scientific research, they are not typically associated with medical diagnoses or treatments.

A Structure-Activity Relationship (SAR) in the context of medicinal chemistry and pharmacology refers to the relationship between the chemical structure of a drug or molecule and its biological activity or effect on a target protein, cell, or organism. SAR studies aim to identify patterns and correlations between structural features of a compound and its ability to interact with a specific biological target, leading to a desired therapeutic response or undesired side effects.

By analyzing the SAR, researchers can optimize the chemical structure of lead compounds to enhance their potency, selectivity, safety, and pharmacokinetic properties, ultimately guiding the design and development of novel drugs with improved efficacy and reduced toxicity.

Maltose is a disaccharide made up of two glucose molecules joined by an alpha-1,4 glycosidic bond. It is commonly found in malted barley and is created during the germination process when amylase breaks down starches into simpler sugars. Maltose is less sweet than sucrose (table sugar) and is broken down into glucose by the enzyme maltase during digestion.

Deoxyguanosine is a chemical compound that is a component of DNA (deoxyribonucleic acid), one of the nucleic acids. It is a nucleoside, which is a molecule consisting of a sugar (in this case, deoxyribose) and a nitrogenous base (in this case, guanine). Deoxyguanosine plays a crucial role in the structure and function of DNA, as it pairs with deoxycytidine through hydrogen bonding to form a rung in the DNA double helix. It is involved in the storage and transmission of genetic information.

Phosphoglucomutase (PGM) is an enzyme involved in carbohydrate metabolism, specifically in the glycolysis and gluconeogenesis pathways. It catalyzes the reversible conversion of glucose-6-phosphate (G6P) to glucose-1-phosphate (G1P), and vice versa.

In humans, there are three isoforms of phosphoglucomutase: PGM1, PGM2, and PGM3, which are encoded by different genes. These isoforms have distinct tissue distributions and functions. For example, PGM1 is widely expressed in various tissues, while PGM2 is primarily found in the brain and testis.

Phosphoglucomutase plays a crucial role in maintaining glucose homeostasis by interconverting G6P and G1P, which are precursors for glycogen synthesis and degradation, respectively. Deficiencies in phosphoglucomutase can lead to metabolic disorders such as muscle phosphorylase deficiency (McArdle disease) or type IV glycogen storage disease (GSD IV).

Trypsin is a proteolytic enzyme, specifically a serine protease, that is secreted by the pancreas as an inactive precursor, trypsinogen. Trypsinogen is converted into its active form, trypsin, in the small intestine by enterokinase, which is produced by the intestinal mucosa.

Trypsin plays a crucial role in digestion by cleaving proteins into smaller peptides at specific arginine and lysine residues. This enzyme helps to break down dietary proteins into amino acids, allowing for their absorption and utilization by the body. Additionally, trypsin can activate other zymogenic pancreatic enzymes, such as chymotrypsinogen and procarboxypeptidases, thereby contributing to overall protein digestion.

Ion exchange chromatography is a type of chromatography technique used to separate and analyze charged molecules (ions) based on their ability to exchange bound ions in a solid resin or gel with ions of similar charge in the mobile phase. The stationary phase, often called an ion exchanger, contains fixed ated functional groups that can attract counter-ions of opposite charge from the sample mixture.

In this technique, the sample is loaded onto an ion exchange column containing the charged resin or gel. As the sample moves through the column, ions in the sample compete for binding sites on the stationary phase with ions already present in the column. The ions that bind most strongly to the stationary phase will elute (come off) slower than those that bind more weakly.

Ion exchange chromatography can be performed using either cation exchangers, which exchange positive ions (cations), or anion exchangers, which exchange negative ions (anions). The pH and ionic strength of the mobile phase can be adjusted to control the binding and elution of specific ions.

Ion exchange chromatography is widely used in various applications such as water treatment, protein purification, and chemical analysis.

Molecular cloning is a laboratory technique used to create multiple copies of a specific DNA sequence. This process involves several steps:

1. Isolation: The first step in molecular cloning is to isolate the DNA sequence of interest from the rest of the genomic DNA. This can be done using various methods such as PCR (polymerase chain reaction), restriction enzymes, or hybridization.
2. Vector construction: Once the DNA sequence of interest has been isolated, it must be inserted into a vector, which is a small circular DNA molecule that can replicate independently in a host cell. Common vectors used in molecular cloning include plasmids and phages.
3. Transformation: The constructed vector is then introduced into a host cell, usually a bacterial or yeast cell, through a process called transformation. This can be done using various methods such as electroporation or chemical transformation.
4. Selection: After transformation, the host cells are grown in selective media that allow only those cells containing the vector to grow. This ensures that the DNA sequence of interest has been successfully cloned into the vector.
5. Amplification: Once the host cells have been selected, they can be grown in large quantities to amplify the number of copies of the cloned DNA sequence.

Molecular cloning is a powerful tool in molecular biology and has numerous applications, including the production of recombinant proteins, gene therapy, functional analysis of genes, and genetic engineering.

Protein Phosphatase 2 (PP2A) is a type of serine/threonine protein phosphatase that plays a crucial role in the regulation of various cellular processes, including signal transduction, cell cycle progression, and metabolism. PP2A is a heterotrimeric enzyme composed of a catalytic subunit (C), a regulatory subunit A (A), and a variable regulatory subunit B (B). The different combinations of the B subunits confer specificity to PP2A, allowing it to regulate a diverse array of cellular targets.

PP2A is responsible for dephosphorylating many proteins that have been previously phosphorylated by protein kinases. This function is essential for maintaining the balance of phosphorylation and dephosphorylation in cells, which is necessary for proper protein function and cell signaling. Dysregulation of PP2A has been implicated in various diseases, including cancer, neurodegenerative disorders, and cardiovascular disease.

Bacterial RNA refers to the genetic material present in bacteria that is composed of ribonucleic acid (RNA). Unlike higher organisms, bacteria contain a single circular chromosome made up of DNA, along with smaller circular pieces of DNA called plasmids. These bacterial genetic materials contain the information necessary for the growth and reproduction of the organism.

Bacterial RNA can be divided into three main categories: messenger RNA (mRNA), ribosomal RNA (rRNA), and transfer RNA (tRNA). mRNA carries genetic information copied from DNA, which is then translated into proteins by the rRNA and tRNA molecules. rRNA is a structural component of the ribosome, where protein synthesis occurs, while tRNA acts as an adapter that brings amino acids to the ribosome during protein synthesis.

Bacterial RNA plays a crucial role in various cellular processes, including gene expression, protein synthesis, and regulation of metabolic pathways. Understanding the structure and function of bacterial RNA is essential for developing new antibiotics and other therapeutic strategies to combat bacterial infections.

Thymidylate synthase (TS) is an essential enzyme in the metabolic pathway for DNA synthesis and repair. It catalyzes the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is a crucial building block for DNA replication and repair. This reaction also involves the methylation of dUMP using a methyl group donated by N5,N10-methylenetetrahydrofolate, resulting in the formation of dihydrofolate as a byproduct. The regeneration of dihydrofolate to tetrahydrofolate is necessary for TS to continue functioning, making it dependent on the folate cycle. Thymidylate synthase inhibitors are used in cancer chemotherapy to interfere with DNA synthesis and replication, leading to cytotoxic effects in rapidly dividing cells.

Divalent cations are ions that carry a positive charge of +2. They are called divalent because they have two positive charges. Common examples of divalent cations include calcium (Ca²+), magnesium (Mg²+), and iron (Fe²+). These ions play important roles in various biological processes, such as muscle contraction, nerve impulse transmission, and bone metabolism. They can also interact with certain drugs and affect their absorption, distribution, and elimination in the body.

Glycolysis is a fundamental metabolic pathway that occurs in the cytoplasm of cells, consisting of a series of biochemical reactions. It's the process by which a six-carbon glucose molecule is broken down into two three-carbon pyruvate molecules. This process generates a net gain of two ATP molecules (the main energy currency in cells), two NADH molecules, and two water molecules.

Glycolysis can be divided into two stages: the preparatory phase (or 'energy investment' phase) and the payoff phase (or 'energy generation' phase). During the preparatory phase, glucose is phosphorylated twice to form glucose-6-phosphate and then converted to fructose-1,6-bisphosphate. These reactions consume two ATP molecules but set up the subsequent breakdown of fructose-1,6-bisphosphate into triose phosphates in the payoff phase. In this second stage, each triose phosphate is further oxidized and degraded to produce one pyruvate molecule, one NADH molecule, and one ATP molecule through substrate-level phosphorylation.

Glycolysis does not require oxygen to proceed; thus, it can occur under both aerobic (with oxygen) and anaerobic (without oxygen) conditions. In the absence of oxygen, the pyruvate produced during glycolysis is further metabolized through fermentation pathways such as lactic acid fermentation or alcohol fermentation to regenerate NAD+, which is necessary for glycolysis to continue.

In summary, glycolysis is a crucial process in cellular energy metabolism, allowing cells to convert glucose into ATP and other essential molecules while also serving as a starting point for various other biochemical pathways.

Adenosine diphosphate glucose (ADP-glucose) is a key intermediate in the biosynthesis of glycogen, which is a complex carbohydrate that serves as a primary form of energy storage in animals, fungi, and bacteria. In this process, ADP-glucose is formed from glucose-1-phosphate and adenosine triphosphate (ATP) through the action of the enzyme ADP-glucose pyrophosphorylase. Once synthesized, ADP-glucose is then used as a substrate for the enzyme glycogen synthase, which catalyzes the addition of glucose units to an existing glycogen molecule, leading to its growth and expansion. This pathway plays a crucial role in regulating cellular energy metabolism and maintaining glucose homeostasis within the body.

Adenosine diphosphate (ADP) is a chemical compound that plays a crucial role in energy transfer within cells. It is a nucleotide, which consists of a adenosine molecule (a sugar molecule called ribose attached to a nitrogenous base called adenine) and two phosphate groups.

In the cell, ADP functions as an intermediate in the conversion of energy from one form to another. When a high-energy phosphate bond in ADP is broken, energy is released and ADP is converted to adenosine triphosphate (ATP), which serves as the main energy currency of the cell. Conversely, when ATP donates a phosphate group to another molecule, it is converted back to ADP, releasing energy for the cell to use.

ADP also plays a role in blood clotting and other physiological processes. In the coagulation cascade, ADP released from damaged red blood cells can help activate platelets and initiate the formation of a blood clot.

Phosphoric monoester hydrolases are a class of enzymes that catalyze the hydrolysis of phosphoric monoesters into alcohol and phosphate. This class of enzymes includes several specific enzymes, such as phosphatases and nucleotidases, which play important roles in various biological processes, including metabolism, signal transduction, and regulation of cellular processes.

Phosphoric monoester hydrolases are classified under the EC number 3.1.3 by the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (IUBMB). The enzymes in this class share a common mechanism of action, which involves the nucleophilic attack on the phosphorus atom of the substrate by a serine or cysteine residue in the active site of the enzyme. This results in the formation of a covalent intermediate, which is then hydrolyzed to release the products.

Phosphoric monoester hydrolases are important therapeutic targets for the development of drugs that can modulate their activity. For example, inhibitors of phosphoric monoester hydrolases have been developed as potential treatments for various diseases, including cancer, neurodegenerative disorders, and infectious diseases.

Hypoxanthine is a purine derivative and an intermediate in the metabolic pathways of nucleotide degradation, specifically adenosine to uric acid in humans. It is formed from the oxidation of xanthine by the enzyme xanthine oxidase. In the body, hypoxanthine is converted to xanthine and then to uric acid, which is excreted in the urine. Increased levels of hypoxanthine in the body can be indicative of various pathological conditions, including tissue hypoxia, ischemia, and necrosis.

Thymidine is a pyrimidine nucleoside that consists of a thymine base linked to a deoxyribose sugar by a β-N1-glycosidic bond. It plays a crucial role in DNA replication and repair processes as one of the four nucleosides in DNA, along with adenosine, guanosine, and cytidine. Thymidine is also used in research and clinical settings for various purposes, such as studying DNA synthesis or as a component of antiviral and anticancer therapies.

Adenosine is a purine nucleoside that is composed of a sugar (ribose) and the base adenine. It plays several important roles in the body, including serving as a precursor for the synthesis of other molecules such as ATP, NAD+, and RNA.

In the medical context, adenosine is perhaps best known for its use as a pharmaceutical agent to treat certain cardiac arrhythmias. When administered intravenously, it can help restore normal sinus rhythm in patients with paroxysmal supraventricular tachycardia (PSVT) by slowing conduction through the atrioventricular node and interrupting the reentry circuit responsible for the arrhythmia.

Adenosine can also be used as a diagnostic tool to help differentiate between narrow-complex tachycardias of supraventricular origin and those that originate from below the ventricles (such as ventricular tachycardia). This is because adenosine will typically terminate PSVT but not affect the rhythm of VT.

It's worth noting that adenosine has a very short half-life, lasting only a few seconds in the bloodstream. This means that its effects are rapidly reversible and generally well-tolerated, although some patients may experience transient symptoms such as flushing, chest pain, or shortness of breath.

Electrophoresis, polyacrylamide gel (EPG) is a laboratory technique used to separate and analyze complex mixtures of proteins or nucleic acids (DNA or RNA) based on their size and electrical charge. This technique utilizes a matrix made of cross-linked polyacrylamide, a type of gel, which provides a stable and uniform environment for the separation of molecules.

In this process:

1. The polyacrylamide gel is prepared by mixing acrylamide monomers with a cross-linking agent (bis-acrylamide) and a catalyst (ammonium persulfate) in the presence of a buffer solution.
2. The gel is then poured into a mold and allowed to polymerize, forming a solid matrix with uniform pore sizes that depend on the concentration of acrylamide used. Higher concentrations result in smaller pores, providing better resolution for separating smaller molecules.
3. Once the gel has set, it is placed in an electrophoresis apparatus containing a buffer solution. Samples containing the mixture of proteins or nucleic acids are loaded into wells on the top of the gel.
4. An electric field is applied across the gel, causing the negatively charged molecules to migrate towards the positive electrode (anode) while positively charged molecules move toward the negative electrode (cathode). The rate of migration depends on the size, charge, and shape of the molecules.
5. Smaller molecules move faster through the gel matrix and will migrate farther from the origin compared to larger molecules, resulting in separation based on size. Proteins and nucleic acids can be selectively stained after electrophoresis to visualize the separated bands.

EPG is widely used in various research fields, including molecular biology, genetics, proteomics, and forensic science, for applications such as protein characterization, DNA fragment analysis, cloning, mutation detection, and quality control of nucleic acid or protein samples.

Ribonucleotides are organic compounds that consist of a ribose sugar, a phosphate group, and a nitrogenous base. They are the building blocks of RNA (ribonucleic acid), one of the essential molecules in all living organisms. The nitrogenous bases found in ribonucleotides include adenine, uracil, guanine, and cytosine. These molecules play crucial roles in various biological processes, such as protein synthesis, gene expression, and cellular energy production. Ribonucleotides can also be involved in cell signaling pathways and serve as important cofactors for enzymatic reactions.

In the context of medicine, "chemistry" often refers to the field of study concerned with the properties, composition, and structure of elements and compounds, as well as their reactions with one another. It is a fundamental science that underlies much of modern medicine, including pharmacology (the study of drugs), toxicology (the study of poisons), and biochemistry (the study of the chemical processes that occur within living organisms).

In addition to its role as a basic science, chemistry is also used in medical testing and diagnosis. For example, clinical chemistry involves the analysis of bodily fluids such as blood and urine to detect and measure various substances, such as glucose, cholesterol, and electrolytes, that can provide important information about a person's health status.

Overall, chemistry plays a critical role in understanding the mechanisms of diseases, developing new treatments, and improving diagnostic tests and techniques.

Endoribonucleases are enzymes that cleave RNA molecules internally, meaning they cut the phosphodiester bond between nucleotides within the RNA chain. These enzymes play crucial roles in various cellular processes, such as RNA processing, degradation, and quality control. Different endoribonucleases recognize specific sequences or structural features in RNA substrates, allowing them to target particular regions for cleavage. Some well-known examples of endoribonucleases include RNase III, RNase T1, and RNase A, each with distinct substrate preferences and functions.

Disaccharides are a type of carbohydrate that is made up of two monosaccharide units bonded together. Monosaccharides are simple sugars, such as glucose, fructose, or galactose. When two monosaccharides are joined together through a condensation reaction, they form a disaccharide.

The most common disaccharides include:

* Sucrose (table sugar), which is composed of one glucose molecule and one fructose molecule.
* Lactose (milk sugar), which is composed of one glucose molecule and one galactose molecule.
* Maltose (malt sugar), which is composed of two glucose molecules.

Disaccharides are broken down into their component monosaccharides during digestion by enzymes called disaccharidases, which are located in the brush border of the small intestine. These enzymes catalyze the hydrolysis of the glycosidic bond that links the two monosaccharides together, releasing them to be absorbed into the bloodstream and used for energy.

Disorders of disaccharide digestion and absorption can lead to various symptoms, such as bloating, diarrhea, and abdominal pain. For example, lactose intolerance is a common condition in which individuals lack sufficient levels of the enzyme lactase, leading to an inability to properly digest lactose and resulting in gastrointestinal symptoms.

Skeletal muscle, also known as striated or voluntary muscle, is a type of muscle that is attached to bones by tendons or aponeuroses and functions to produce movements and support the posture of the body. It is composed of long, multinucleated fibers that are arranged in parallel bundles and are characterized by alternating light and dark bands, giving them a striped appearance under a microscope. Skeletal muscle is under voluntary control, meaning that it is consciously activated through signals from the nervous system. It is responsible for activities such as walking, running, jumping, and lifting objects.

Antimetabolites are a class of antineoplastic (chemotherapy) drugs that interfere with the metabolism of cancer cells and inhibit their growth and proliferation. These agents are structurally similar to naturally occurring metabolites, such as amino acids, nucleotides, and folic acid, which are essential for cellular replication and growth. Antimetabolites act as false analogs and get incorporated into the growing cells' DNA or RNA, causing disruption of the normal synthesis process, leading to cell cycle arrest and apoptosis (programmed cell death).

Examples of antimetabolite drugs include:

1. Folate antagonists: Methotrexate, Pemetrexed
2. Purine analogs: Mercaptopurine, Thioguanine, Fludarabine, Cladribine
3. Pyrimidine analogs: 5-Fluorouracil (5-FU), Capecitabine, Cytarabine, Gemcitabine

These drugs are used to treat various types of cancers, such as leukemias, lymphomas, breast, ovarian, and gastrointestinal cancers. Due to their mechanism of action, antimetabolites can also affect normal, rapidly dividing cells in the body, leading to side effects like myelosuppression (decreased production of blood cells), mucositis (inflammation and ulceration of the gastrointestinal tract), and alopecia (hair loss).

Adenine is a purine nucleotide base that is a fundamental component of DNA and RNA, the genetic material of living organisms. In DNA, adenine pairs with thymine via double hydrogen bonds, while in RNA, it pairs with uracil. Adenine is essential for the structure and function of nucleic acids, as well as for energy transfer reactions in cells through its role in the formation of adenosine triphosphate (ATP), the primary energy currency of the cell.

Trehalose is a type of disaccharide, which is a sugar made up of two monosaccharides. It consists of two glucose molecules joined together in a way that makes it more stable and resistant to breakdown by enzymes and heat. This property allows trehalose to be used as a protectant for biological materials during freeze-drying and storage, as well as a food additive as a sweetener and preservative.

Trehalose is found naturally in some plants, fungi, insects, and microorganisms, where it serves as a source of energy and protection against environmental stresses such as drought, heat, and cold. In recent years, there has been interest in the potential therapeutic uses of trehalose for various medical conditions, including neurodegenerative diseases, diabetes, and cancer.

Medically speaking, trehalose may be used in some pharmaceutical formulations as an excipient or stabilizer, and it is also being investigated as a potential therapeutic agent for various diseases. However, its use as a medical treatment is still not widely established, and further research is needed to determine its safety and efficacy.

Chemical phenomena refer to the changes and interactions that occur at the molecular or atomic level when chemicals are involved. These phenomena can include chemical reactions, in which one or more substances (reactants) are converted into different substances (products), as well as physical properties that change as a result of chemical interactions, such as color, state of matter, and solubility. Chemical phenomena can be studied through various scientific disciplines, including chemistry, biochemistry, and physics.

Enzyme stability refers to the ability of an enzyme to maintain its structure and function under various environmental conditions, such as temperature, pH, and the presence of denaturants or inhibitors. A stable enzyme retains its activity and conformation over time and across a range of conditions, making it more suitable for industrial and therapeutic applications.

Enzymes can be stabilized through various methods, including chemical modification, immobilization, and protein engineering. Understanding the factors that affect enzyme stability is crucial for optimizing their use in biotechnology, medicine, and research.

In enzymology, an uridine phosphorylase (EC 2.4.2.3) is an enzyme that catalyzes the chemical reaction uridine + phosphate ⇌ {\ ... Other names in common use include pyrimidine phosphorylase, UrdPase, UPH, and UPase. This enzyme participates in pyrimidine ... PAEGE LM, SCHLENK F (1952). "Bacterial uracil riboside phosphorylase". Arch. Biochem. Biophys. 40 (1): 42-9. doi:10.1016/0003- ... Pontis H, Degerstedt G, Reichard P (1961). "Uridine and deoxyuridine phosphorylases from Ehrlich ascites tumor". Biochim. ...
Phosphorylase a and phosphorylase b each exist in two forms: a T (tense) inactive state and an R (relaxed) state. Phosphorylase ... Glycogen phosphorylase is one of the phosphorylase enzymes (EC 2.4.1.1). Glycogen phosphorylase catalyzes the rate-limiting ... Glycogen phosphorylase kinase activates glycogen phosphorylase in the same manner mentioned previously. Glycogen phosphorylase ... PP1 dephosphorylates glycogen phosphorylase a, reforming the inactive glycogen phosphorylase b. The phosphodiesterase converts ...
In enzymology, a laminaribiose phosphorylase (EC 2.4.1.31) is an enzyme that catalyzes the chemical reaction 3-beta-D-glucosyl- ... Specificity of laminaribiose phosphorylase from Astasia ocellata". Arch. Biochem. Biophys. 121 (2): 443-51. doi:10.1016/0003- ...
... is a form of phosphorylase similar to glycogen phosphorylase, except that it acts upon starch instead of ... Two distinct forms of starch phosphorylase, plastidic phosphorylase and cytosolic phosphorylase, have been consistently ... The plant alpha-glucan phosphorylase, commonly called starch phosphorylase (EC 2.4.1.1), is largely known for the ... Starch phosphorylase catalyzes the reversible transfer of glucosyl units from glucose-1-phosphate to the nonreducing end of ...
In enzymology, a kojibiose phosphorylase (EC 2.4.1.230) is an enzyme that catalyzes the chemical reaction 2-alpha-D-glucosyl-D- ... Sugimoto T, Kurimoto M, Tsujisaka Y (1999). "Purification and characterization of a novel phosphorylase, kojibiose ... "Enzymatic synthesis of kojioligosaccharides using kojibiose phosphorylase". J. Biosci. Bioeng. 92 (2): 177-82. doi:10.1263/jbb. ... phosphorylase, from Thermoanaerobium brockii". J. Appl. Glycosci. 46: 423-429. Chaen H, Nishimoto T, Nakada T, Fukuda S, ...
Putman EW, Litt CF, Hassid WZ (1955). "The structure of D-glucose-D-xylose synthesized by maltose phosphorylase". J. Am. Chem. ... In enzymology, a maltose phosphorylase (EC 2.4.1.8) is an enzyme that catalyzes the chemical reaction maltose + phosphate ⇌ {\ ...
... (PNP-ĮĮ) is a kind of purine nucleoside phosphorylases (PNPs) in E. coli and it is located in the ... Xanthosine phosphorylase, also known as inosine-guanosine phosphorylase, is a catalytic enzyme encoded by the XapA gene in E. ... Xanthosine phosphorylase is a purine nucleoside phosphorylase, it involves in the purine metabolism. When human lacks PNP, ... These actions take place in the cytoplasm so xanthosine phosphorylase is located in the cytoplasm. Xanthosine phosphorylase ...
Polynucleotide+Phosphorylase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology (Articles ... Polynucleotide Phosphorylase (PNPase) is a bifunctional enzyme with a phosphorolytic 3' to 5' exoribonuclease activity and a 3 ... I. Polynucleotide phosphorylase of azotobacter vinelandii". Biochimica et Biophysica Acta. 20 (1): 269-85. doi:10.1016/0006- ... Yehudai-Resheff S, Hirsh M, Schuster G (August 2001). "Polynucleotide phosphorylase functions as both an exonuclease and a poly ...
The enzyme phosphorylase a phosphatase (EC 3.1.3.17) catalyzes the reaction [phosphorylase a] + 4 H2O ⇌ {\displaystyle \ ... Rall TW, Wosilait WD, Sutherland EW (1956). "The interconversion of phosphorylase a and phosphorylase b from dog heart muscle ... The systematic name is [phosphorylase a] phosphohydrolase. Other names in common use include PR-enzyme, phosphorylase a ... Brandt H, Capulong ZL, Lee EY (1975). "Purification and properties of rabbit liver phosphorylase phosphatase". J. Biol. Chem. ...
... (PhK) is a serine/threonine-specific protein kinase which activates glycogen phosphorylase to release ... Fischer EH, Krebs EG (1955). "Conversion of phosphorylase b to phosphorylase a in muscle extracts". J Biol Chem. 216 (1): 121- ... 2002). "Three-dimensional structure of phosphorylase kinase at 22 A resolution and its complex with glycogen phosphorylase b". ... Defects in phosphorylase kinase genes are the cause of glycogen storage disease type IX (GSD type IX) and GSD type VI (formerly ...
... which suggests that thymidine phosphorylase has several allosteric and/or catalytic sites as well. Thymidine phosphorylase is a ... an inhibitor of thymidine phosphorylase, suggesting that the enzymatic activity of thymidine phosphorylase is required for its ... pyrimidine deoxynucleoside phosphorylase, and thymidine:phosphate deoxy-D-ribosyltransferase. Thymidine phosphorylase catalyzes ... Thymidine phosphorylase (EC 2.4.2.4) is an enzyme that is encoded by the TYMP gene and catalyzes the reaction: thymidine + ...
The reaction is catalysed by EC 2.4.2.2, pyrimidine-nucleoside phosphorylase, EC 2.4.2.3, uridine phosphorylase, and EC 2.4.2.4 ... Yamada EW (1964). "The effect of cortisol administration on the activities of uridine and deoxyuridine phosphorylases of normal ... In enzymology, a deoxyuridine phosphorylase is an enzyme that catalyzes the chemical reaction 2'-deoxyuridine + phosphate ⇌ {\ ... thymidine phosphorylase. These enzymes belong to the family of glycosyltransferases, specifically the pentosyltransferases. ...
In enzymology, a cellodextrin phosphorylase (EC 2.4.1.49) is an enzyme that catalyzes the chemical reaction (1,4-beta-D- ...
The Mechanism of Action of Sucrose Phosphorylase BRENDA Sucrose Phosphorylase Reaction Mechanism Portal: Biology (All articles ... Sucrose phosphorylase catalyzes the conversion of sucrose to D-fructose and α-D-glucose-1-phosphate. It has been shown in ... Sucrose phosphorylase (EC 2.4.1.7) is an important enzyme in the metabolism of sucrose and regulation of other metabolic ... Sucrose phosphorylase is in the class of hexosyltransferases. More specifically it has been placed in the retaining glycoside ...
In enzymology, a guanosine phosphorylase (EC 2.4.2.15) is an enzyme that catalyzes the chemical reaction guanosine + phosphate ...
"Purification and characterization of purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase from Bacillus ... In enzymology, a pyrimidine-nucleoside phosphorylase (EC 2.4.2.2) is an enzyme that catalyzes the chemical reaction a ... Saunders PP, Wilson BA, Saunders GF (1969). "Purification and comparative properties of a pyrimidine nucleoside phosphorylase ...
In enzymology, an urate-ribonucleotide phosphorylase (EC 2.4.2.16) is an enzyme that catalyzes the chemical reaction urate D- ... Laster L, Blair A (October 1963). "An intestinal phosphorylase for uric acid ribonucleoside". The Journal of Biological ... Other names in common use include UAR phosphorylase, and urate-ribonucleotide:phosphate D-ribosyltransferase. This enzyme ...
In enzymology, a trehalose 6-phosphate phosphorylase (EC 2.4.1.216) is an enzyme that catalyzes the chemical reaction alpha, ... Andersson U, Levander F, Radstrom P (2001). "Trehalose-6-phosphate phosphorylase is part of a novel metabolic pathway for ...
... (EC 2.7.7.69, VTC2, VTC5) is an enzyme with systematic name GDP:alpha-L-galactose 1-phosphate ... GDP-L-galactose+phosphorylase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology (EC 2.7. ... Linster CL, Adler LN, Webb K, Christensen KC, Brenner C, Clarke SG (July 2008). "A second GDP-L-galactose phosphorylase in ... "Arabidopsis VTC2 encodes a GDP-L-galactose phosphorylase, the last unknown enzyme in the Smirnoff-Wheeler pathway to ascorbic ...
In enzymology, an alpha,alpha-trehalose phosphorylase (EC 2.4.1.64) is an enzyme that catalyzes the chemical reaction alpha, ... This enzyme is also called trehalose phosphorylase. This enzyme participates in starch and sucrose metabolism. Belocopitow E, ... Marechal LR (1970). "Trehalose phosphorylase from Euglena gracilis". Biochim. Biophys. Acta. 198 (1): 151-4. doi:10.1016/0005- ...
... (abbreviation: GPBB) is an isoenzyme of glycogen phosphorylase. This isoform of the enzyme ... 2005). "Glycogen phosphorylase BB in acute coronary syndromes". Clin. Chem. Lab. Med. 43 (12): 1351-8. doi:10.1515/CCLM. ... Other enzymes related to glycogen phosphorylase are abbreviated as GPLL (liver) and GPMM (muscle). Apple FS, Wu AH, Mair J, et ...
"eMedicine - Purine Nucleoside Phosphorylase Deficiency : Article by Alan P Knutsen". Retrieved July 25, 2010. "Boy first in UK ... Purine nucleoside phosphorylase deficiency is a rare autosomal recessive metabolic disorder which results in immunodeficiency. ... Toro A, Grunebaum E (Oct 2006). "TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency ... Markert ML (1991). "Purine nucleoside phosphorylase deficiency". Immunodefic Rev. 3 (1): 45-81. PMID 1931007. Online Mendelian ...
MTA phosphorylase, MeSAdo phosphorylase, MeSAdo/Ado phosphorylase, methylthioadenosine phosphorylase, methylthioadenosine ... In enzymology, a S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) is an enzyme that catalyzes the chemical reaction S- ... Garbers DL (1978). "Demonstration of 5'-methylthioadenosine phosphorylase activity in various rat tissues. Some properties of ... Gambacorta A, Zappia V (1979). "5'-Methylthioadenosine phosphorylase from Caldariella acidophila Purification and properties". ...
In enzymology, a 1,3-beta-oligoglucan phosphorylase (EC 2.4.1.30) is an enzyme that catalyzes the chemical reaction (1,3-beta-D ... I. Isolation and some properties of a beta-1,3-oligoglucan phosphorylase". Biochimica et Biophysica Acta (BBA) - Enzymology. ... Comparative studies between laminaribiose- and beta-1,3-oligoglucan phosphorylase". Biochimica et Biophysica Acta (BBA) - ... 3-oligoglucan phosphorylase. Marechal LR (1967). "Beta-1,3-oligoglucan:orthophosphate glucosyltransferases from Euglena ...
... (EC 2.4.2.44, MTIP, MTI phosphorylase, methylthioinosine phosphorylase) is an enzyme with ... S-methyl-5'-thioinosine+phosphorylase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology ... Guan R, Ho MC, Almo SC, Schramm VL (February 2011). "Methylthioinosine phosphorylase from Pseudomonas aeruginosa. Structure and ...
In enzymology, an alpha,alpha-trehalose phosphorylase (configuration-retaining) (EC 2.4.1.231) is an enzyme that catalyzes the ... Eis C, Watkins M, Prohaska T, Nidetzky B (2001). "Fungal trehalose phosphorylase: kinetic mechanism, pH-dependence of the ... This enzyme is also called trehalose phosphorylase[ambiguous]. Eis C, Nidetzky B (2002). "Substrate-binding recognition and ... Nidetzky B, Eis C (2001). "Alpha-retaining glucosyl transfer catalysed by trehalose phosphorylase from Schizophyllum commune: ...
In enzymology, a 1,3-beta-D-glucan phosphorylase (EC 2.4.1.97) is an enzyme that catalyzes the chemical reaction (1,3-beta-D- ... Albrecht GJ, Kauss H (1971). "Purification, crystallization and properties of a beta-(1->3)-glucan phosphorylase from ...
In enzymology, a 1,3-beta-galactosyl-N-acetylhexosamine phosphorylase (EC 2.4.1.211) is an enzyme that catalyzes the chemical ... Derensy-Dron D, Krzewinski F, Brassart C, Bouquelet S (1999). "Beta-1,3-galactosyl-N-acetylhexosamine phosphorylase from ...
... (EC 2.4.1.282, cphy1019 (gene)) is an enzyme with systematic name 3-O-alpha-D- ... 3-O-alpha-D-glucosyl-L-rhamnose+phosphorylase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: ... Nihira T, Nakai H, Kitaoka M (March 2012). "3-O-α-D-glucopyranosyl-L-rhamnose phosphorylase from Clostridium phytofermentans". ...
... (EC 2.4.1.281, mannosylglucose phosphorylase) is an enzyme with systematic name 4-O ... 4-O-beta-D-mannosyl-D-glucose+phosphorylase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: ... "New microbial mannan catabolic pathway that involves a novel mannosylglucose phosphorylase". Biochemical and Biophysical ...
... glycogen phosphorylase starch phosphorylase maltodextrin phosphorylase Enzymes that break down nucleosides into their ... Phosphorylase is also a common name used for glycogen phosphorylase in honor of Earl W. Sutherland Jr., who in the late 1930s ... Phosphorylase a is the more active R form of glycogen phosphorylase that is derived from the phosphorylation of the less active ... Phosphorylases should not be confused with phosphatases, which remove phosphate groups. In more general terms, phosphorylases ...
... may refer to: Thymidine phosphorylase Uridine phosphorylase This article includes a list of related ...
In enzymology, a cellobiose phosphorylase (EC 2.4.1.20) is an enzyme that catalyzes the chemical reaction cellobiose + ... Alexander JK (June 1968). "Purification and specificity of cellobiose phosphorylase from Clostridium thermocellum". The Journal ...
Nigerose+phosphorylase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology (EC 2.4.1). ... Nigerose phosphorylase (EC 2.4.1.279, cphy1874 (gene)) is an enzyme with systematic name 3-O-alpha-D-glucopyranosyl-D- ... Nihira T, Nakai H, Chiku K, Kitaoka M (February 2012). "Discovery of nigerose phosphorylase from Clostridium phytofermentans". ...
... , PNP, PNPase or inosine phosphorylase (EC 2.4.2.1) is an enzyme that in humans is encoded by ... Other names in common use include: inosine phosphorylase PNPase PUNPI PUNPII inosine-guanosine phosphorylase nucleotide ... phosphatase purine deoxynucleoside phosphorylase purine deoxyribonucleoside phosphorylase purine nucleoside phosphorylase ... Purine nucleoside phosphorylase deficiency Canduri F, dos Santos DM, Silva RG, Mendes MA, Basso LA, Palma MS, de Azevedo WF, ...
... (EC 2.4.1.280, chbP (gene)) is an enzyme with the systematic name N,N'-diacetylchitobiose ... N,N'-diacetylchitobiose+phosphorylase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology ... Hidaka M, Honda Y, Kitaoka M, Nirasawa S, Hayashi K, Wakagi T, Shoun H, Fushinobu S (June 2004). "Chitobiose phosphorylase from ... It is believed that N,N'-diacetylchitobiose phosphorylase is an integral part of the phosphoenolpyruvate:glucose ...
GDP-D-glucose+phosphorylase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology (EC 2.7.7) ... GDP-D-glucose phosphorylase (EC 2.7.7.78) is an enzyme with systematic name GDP:alpha-D-glucose 1-phosphate guanylyltransferase ... Adler LN, Gomez TA, Clarke SG, Linster CL (June 2011). "A novel GDP-D-glucose phosphorylase involved in quality control of the ...
"Entrez Gene: PHKA1 phosphorylase kinase, alpha 1 (muscle)". Brushia RJ, Walsh DA (1999). "Phosphorylase kinase: the complexity ... It is the muscle isoform of Phosphorylase kinase (PhK). The PHKA1 gene encodes the alpha subunit of muscle phosphorylase kinase ... Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform is an enzyme that in humans is encoded by the PHKA1 ... Phosphorylase kinase consists of 4 copies of an alpha-beta-gamma-delta tetramer. The alpha, beta (PHKB; MIM 172490), and gamma ...
  • Phosphorylase is also a common name used for glycogen phosphorylase in honor of Earl W. Sutherland Jr., who in the late 1930s discovered it as the first phosphorylase. (wikipedia.org)
  • Phosphorylase a is the more active R form of glycogen phosphorylase that is derived from the phosphorylation of the less active R form, phosphorylase b with associated AMP. (wikipedia.org)
  • Some disorders are related to phosphorylases: Glycogen storage disease type V - muscle glycogen Glycogen storage disease type VI - liver glycogen Hydrolase Nelson DL, Lehninger AL, Cox MM (2005). (wikipedia.org)
  • The design of glycogen phosphorylase (GP) inhibitors targeting the catalytic site of the enzyme is a promising strategy for a better control of hyperglycaemia in the context of type 2 diabetes. (rsc.org)
  • Here, we used a novel glycogen phosphorylase inhibitor, CP-316,819 ([ R - R *, S *]-5-chloro- N -[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1 H -indole-2-carboxamide), that causes glycogen accumulation under normoglycemic conditions but permits glycogen utilization when glucose concentrations are low. (aspetjournals.org)
  • The enzyme couples muscle contraction with energy production via glycogenolysis--glycolysis by catalyzing the Ca(2+)-dependent phosphorylation and activation of glycogen phosphorylase b. (expasy.org)
  • Magnetic Luminex Assay Kit for Glycogen Phosphorylase, Liver (PYGL) ,etc. (uscnk.com)
  • Phosphorylases are enzymes that catalyze the addition of a phosphate group from an inorganic phosphate (phosphate+hydrogen) to an acceptor.They include allosteric enzymes that catalyze the production of glucose-1-phosphate from a glucan such as glycogen, starch or maltodextrin. (targetmol.com)
  • CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 μM in the presence of glucose, 5- to 10-fold less potent in the absence of glucos. (targetmol.com)
  • Ingliforib is a novel glycogen phosphorylase inhibitor,has antihyperglycemic and cardioprotective properties. (targetmol.com)
  • Glycogen phosphorylase kinase β-subunit (PHKB) is a regulatory subunit of phosphorylase kinase (PHK), involving in the activation of glycogen phosphorylase (GP) and the regulation of glycogen breakdown. (ijbs.com)
  • As is the case with rabbit muscle phosphorylase a the dimer a is the active form of frog muscle phosphorylase a with glycogen as the substrate. (northwestern.edu)
  • The extract showed good inhibition toward rat intestinal maltase and rabbit glycogen phosphorylase (GP) b, with IC 50 values of 45 and 7.4 μg/ml, respectively. (breakawaymatcha.com)
  • Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors. (lu.se)
  • In more general terms, phosphorylases are enzymes that catalyze the addition of a phosphate group from an inorganic phosphate (phosphate + hydrogen) to an acceptor, not to be confused with a phosphatase (a hydrolase) or a kinase (a phosphotransferase). (wikipedia.org)
  • Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. (nih.gov)
  • A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency. (nih.gov)
  • Sodium Monofluorophosphate is a competitive inhibitor of pyruvate kinase and alkaline phosphatase, which also irreversibly inhibits phosphorylase phosphatase. (targetmol.com)
  • Phosphorylase kinase is a 1.3 MDa hexadecameric holoenzyme. (phosphorylase-signal.com)
  • Yang W, Zhang C, Li Y, Jin A, Sun Y, Yang X, Wang B, Guo W. Phosphorylase Kinase β Represents a Novel Prognostic Biomarker and Inhibits Malignant Phenotypes of Liver Cancer Cell. (ijbs.com)
  • Frog muscle phosphorylase b can be converted into the phosphorylated form (a) by rabbit skeletal muscle phosphorylase b kinase, adenosine triphosphate (ATP), and Mg 2+ . (northwestern.edu)
  • Frog muscle phosphorylase b can be converted into the phosphorylated form (a) by rabbit skeletal muscle phosphorylase b kinase, adenosine triphosphate (ATP), and Mg2+. (northwestern.edu)
  • Uridine phosphorylase (UP) is a key enzyme in the pyrimidine salvage pathway that catalyses the reversible phosphorolysis of uridine to uracil and ribose 1-phosphate. (rcsb.org)
  • Purine nucleoside phosphorylase is a ubiquitously expressed enzyme of the purine salvage pathway as is adenosine deaminase, deficiency of which also causes immunodeficiency. (frontiersin.org)
  • The enzyme phosphorylates a specific serine residue in each of the subunits of the dimeric phosphorylase b. (expasy.org)
  • The enzyme differs from mammalian muscle phosphorylase a in that the equilibrium between phosphorylase a dimer and phosphorylase a tetramer is shifted in the direction of the dimer. (northwestern.edu)
  • Purine nucleoside phosphorylase (PNP) is the key enzyme of the purine salvage pathway. (biospot.eu)
  • The TYMP gene provides instructions for making an enzyme called thymidine phosphorylase. (medlineplus.gov)
  • First, a sucrose phosphorylase (SPase) mutant with higher enzyme activity was obtained by experimental screening . (bvsalud.org)
  • Purine nueoside phosphorylase (PNP) deficiency causes a form of severe combined immunodeficiency (SCID) characterized by profound T cell deficiency, failure to thrive (FTT), recurrent deep seeded infection, developmental delay, progressive neurological deterioration, and autoimmune complications. (medscape.com)
  • [ 2 , 3 ] One disorder is adenosine deaminase (ADA) deficiency, which is Online Mendelian Inheritance in Man (OMIM) subject number 102700, and the other is purine nucleoside phosphorylase (PNP) deficiency, which is OMIM subject number 164050. (medscape.com)
  • In purine nucleoside phosphorylase deficiency, similar changes occur, resulting in elevated deoxy-GTP (dGTP) levels. (medscape.com)
  • In a further description of the mechanism of T-cell depletion in purine nucleoside phosphorylase deficiency, Arpaia et al reported increased in vivo apoptosis of T cells and increased in vitro sensitivity to gamma irradiation in a murine model. (medscape.com)
  • [ 4 ] The immune deficiency in purine nucleoside phosphorylase deficiency may be the result of inhibited mitochondrial DNA repair due to the accumulation of dGTP in the mitochondria. (medscape.com)
  • Purine nucleoside phosphorylase (PNP) deficiency, a rare autosomal recessive metabolic disease causes combined immunodeficiency and developmental delay, hypotonia, and spasticity. (frontiersin.org)
  • Purine nucleoside phosphorylase (PNP) deficiency (OMIM 613179) is a rare autosomal recessive metabolic disease leading to combined immunodeficiency and neurological abnormalities, which may include developmental delay, hypotonia, and spasticity ( 1 , 2 ). (frontiersin.org)
  • INTRODUCTION - Purine nucleoside phosphorylase (PNP) deficiency (MIM #613179) is a rare, autosomal recessive, inborn error of immunity (IEI) [ 1-3 ]. (medilib.ir)
  • Diagnosis of purine nucleoside phosphorylase deficiency is by DNA analysis. (msdmanuals.com)
  • Treatment of purine nucleoside phosphorylase deficiency is with bone marrow or stem cell transplantation. (msdmanuals.com)
  • Crystal structures of escherichia coli uridine phosphorylase in two native and three complexed forms reveal basis of substrate specificity, induced conformational changes and influence of potassium. (expasy.org)
  • Thymidine Phosphorylase antibody LS-C699697 is a Cy3-conjugated rabbit polyclonal antibody to rat Thymidine Phosphorylase (TP) (aa33-290). (lsbio.com)
  • The following product was used in this experiment: Thymidine Phosphorylase Polyclonal Antibody from Thermo Fisher Scientific, catalog # PA5-17098, RRID AB_10984207. (thermofisher.cn)
  • In both adenosine deaminase and purine nucleoside phosphorylase deficiencies, thymocytes are thought to be selectively destroyed because of elevated levels of dATP and dGTP. (medscape.com)
  • These hexameric structures confirm the overall structural similarity of UP to E.coli purine nucleoside phosphorylase (PNP) whereby, in the presence of substrate, each displays a closed conformation resulting from a concerted movement that closes the active site cleft. (rcsb.org)
  • Previous studies have revealed that the adenosine 5′-monophosphate phosphorylase of Thermococcus kodakarensis ( Tk AMPpase) forms large soluble multimers with high thermal stability. (tu-berlin.de)
  • Modification of regulatory and catalytic properties of phosphorylase-b by irradiation and heat. (nebraska.edu)
  • In biochemistry, phosphorylases are enzymes that catalyze the addition of a phosphate group from an inorganic phosphate (phosphate+hydrogen) to an acceptor. (wikipedia.org)
  • Phosphorylases should not be confused with phosphatases, which remove phosphate groups. (wikipedia.org)
  • Other names in common use include UAR phosphorylase , and urate-ribonucleotide:phosphate D-ribosyltransferase . (wikipedia.org)
  • Unexpectedly, the reaction is stimulated by inorganic phosphate, and our data reveal that MbcT is a NAD+ phosphorylase. (figshare.com)
  • There are 4 moles of pyridoxal 5′-phosphate and 4 moles of orthophosphate bound to each 370,000 g of frog skeletal muscle phosphorylase a. (northwestern.edu)
  • A platelet-derived endothelial growth factor (PD-ECGF), same as thymidine phosphorylase (TP) or gliostatin. (thermofisher.cn)
  • For muscle phosphorylase but not liver phosphorylase, this is accompanied by a further dimerization to form a tetrameric phosphorylase. (expasy.org)
  • Recombinant human thymidine phosphorylase catalyzes the reaction of arsenate with thymidine to form thymine and 2-deoxyribose 1-arsenate, which rapidly decomposes to 2-deoxyribose and inorganic arsenate. (elsevierpure.com)
  • A redetermination of the molecular weight of rabbit muscle phosphorylase b by sedimentation equilibrium and by sedimentation velocity and diffusion gave a value of 185,000. (northwestern.edu)
  • The amino acid compositions of frog, rabbit, and human skeletal muscle phosphorylases are quite similar, but frog and rabbit muscle enzymes differ immunologically. (northwestern.edu)
  • The purification of frog skeletal muscle phosphorylase is described. (northwestern.edu)
  • Both types (b and a) of frog muscle phosphorylase appear to be essentially homogenous by a variety of criteria. (northwestern.edu)
  • The molecular weight of frog muscle phosphorylase b was determined by sedimentation equilibrium and found to be 188,000 g. (northwestern.edu)
  • Several kinetic parameters of frog muscle phosphorylase a have been determined. (northwestern.edu)
  • Polynucleotide phosphorylase (PNPase) is a processive exoribonuclease that contributes to messenger RNA turnover and quality control of ribosomal RNA precursors in many bacterial species. (port.ac.uk)
  • The expression of thymidine phosphorylase (TP), a potent chemotactic factor for endothelial cells, was studied in 60 adenocarcinomas of the gallbladder, by use of immunohistochemical techniques. (ox.ac.uk)
  • TYMP gene variants greatly reduce or eliminate the activity of thymidine phosphorylase. (medlineplus.gov)
  • A loss of thymidine phosphorylase activity and the resulting buildup of thymidine disrupt the usual maintenance and repair of mtDNA. (medlineplus.gov)
  • The structure of the transition state confirms that human thymidine phosphorylase proceeds through an S N 2-like transition state with bond orders of 0.50 to the thymine leaving group and 0.33 to the attacking oxygen nucleophile. (elsevierpure.com)
  • Birck, MR & Schramm, VL 2004, ' Nucleophilic Participation in the Transition State for Human Thymidine Phosphorylase ', Journal of the American Chemical Society , vol. 126, no. 8, pp. 2447-2453. (elsevierpure.com)
  • Arbutin Production through the Engineering of Sucrose Phosphorylase Combined with Engineered Cell Modification. (bvsalud.org)
  • Contrary findings exist according to the prognostic and predictive impact of thymidine phosphorylase (TP) expression in breast cancer. (uni-luebeck.de)
  • When Do Symptoms of Purine nucleoside phosphorylase deficiency Begin? (nih.gov)
  • Purine nucleoside phosphorylase deficiency is a disorder of the immune system called an immunodeficiency. (medlineplus.gov)
  • The shortage of immune system cells in people with purine nucleoside phosphorylase deficiency results in repeated and persistent infections typically beginning in infancy or early childhood. (medlineplus.gov)
  • The infections can be very serious or life-threatening, and without successful treatment to restore immune function, children with purine nucleoside phosphorylase deficiency usually do not survive past childhood. (medlineplus.gov)
  • Infants with purine nucleoside phosphorylase deficiency typically grow more slowly than healthy babies. (medlineplus.gov)
  • People with purine nucleoside phosphorylase deficiency are also at increased risk of developing autoimmune disorders, which occur when the immune system malfunctions and attacks the body's tissues and organs. (medlineplus.gov)
  • Purine nucleoside phosphorylase deficiency is caused by mutations in the PNP gene. (medlineplus.gov)
  • The shortage of T cells and sometimes B cells results in the immune problems characteristic of purine nucleoside phosphorylase deficiency. (medlineplus.gov)
  • Damage to brain cells caused by buildup of dGTP is thought to underlie the neurological problems that occur in some people with purine nucleoside phosphorylase deficiency. (medlineplus.gov)
  • Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry. (medscape.com)
  • Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. (medscape.com)
  • Available at https://ghr.nlm.nih.gov/condition/purine-nucleoside-phosphorylase-deficiency . (medscape.com)
  • Diagnosis of purine nucleoside phosphorylase deficiency is by DNA analysis. (msdmanuals.com)
  • Treatment of purine nucleoside phosphorylase deficiency is with bone marrow or stem cell transplantation. (msdmanuals.com)
  • Patients with high thymidine phosphorylase ( TP) gene expression (n = 62, dotted line) in tumour tissues exhibited significantly longer time to progression compared with patients with low expression (n = 63, solid line). (medscape.com)
  • TP Thymidine Phosphorylase. (medscape.com)
  • Patient and tumour characteristics subgrouped according to high or low thymidine phosphorylase expression. (medscape.com)
  • Prognoses in cases of uterine cervical squamous cell carcinoma treated with radiotherapy were investigated in association with immunohistochemical expression of an angiogenic factor, thymidine phosphorylase (TP). (bmj.com)
  • The angiogenic factor thymidine phosphorylase (TP) is highly expressed in human monocytes and macrophages, and its expression has been linked to the pathology and progression of solid tumors, rheumatoid arthritis, and gastric ulcers. (elsevierpure.com)
  • Zhu, GH & Schwartz, EL 2003, ' Expression of the Angiogenic Factor Thymidine Phosphorylase in THP-1 Monocytes: Induction by Autocrine Tumor Necrosis Factor-α and Inhibition by Aspirin ', Molecular Pharmacology , vol. 64, no. 5, pp. 1251-1258. (elsevierpure.com)
  • Thymidine phosphorylase (TP) anabolises formation of pyrimidine nucleosides available for DNA synthesis, whereas dihydropyrimidine dehydrogenase (DPD) catabolises the degradation of pyrimidine bases, thereby reducing levels of uracil and thymine available for DNA synthesis. (elsevierpure.com)
  • Focal expression of thymidine phosphorylase associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer. (ox.ac.uk)
  • In more general terms, phosphorylases are enzymes that catalyze the addition of a phosphate group from an inorganic phosphate (phosphate + hydrogen) to an acceptor, not to be confused with a phosphatase (a hydrolase) or a kinase (a phosphotransferase). (wikipedia.org)
  • Phosphorylase Kinase (PhK) is an essential regulatory enzyme in the glycogenolysis cascade. (ku.edu)
  • Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, which has a major regulatory role in the breakdown of glycogen. (nih.gov)
  • Phosphorylase kinase is a 1.3 MDa hexadecameric holoenzyme. (phosphorylase-signal.com)
  • A class of CAZymes, known as glycoside phosphorylases (GPs) catalyze the reversible phosphorolysis of glycosidic bonds, releasing sugar 1-phosphates and have considerable potential as catalysts for the assembly of useful carbohydrates for products ranging from functional foods and prebiotics to novel materials. (ubc.ca)
  • Biocatalytic nucleoside (trans-)glycosylations catalyzed by nucleoside phosphorylases have graduated to a practical and convenient approach to the preparation of modified nucleosides, which are important pharmaceuticals for the treatment of various cancers and viral infections. (chemrxiv.org)
  • Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients. (medscape.com)
  • Previous studies have revealed that the adenosine 5′-monophosphate phosphorylase of Thermococcus kodakarensis ( Tk AMPpase) forms large soluble multimers with high thermal stability. (tu-berlin.de)
  • A mixed type inhibitor of muscle glycogen phosphorylase (K i = 930 nM). (emdmillipore.com)
  • The fourth-generation immucillin derivative (DI4G), a potent inhibitor of purine nucleoside phosphorylase, has been proposed as a promising agent in the treatment of diseases associated with T cell activation. (fiocruz.br)
  • Catalysis of the reaction: 4 ATP + 2 phosphorylase b = 4 ADP + phosphorylase a. (yeastrc.org)
  • Evidence from purine nucleoside phosphorylase-deficient mice. (medscape.com)
  • Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug system. (expasy.org)
  • It is rare for this deletion to occur in primary prostate tumors, yet approximately 10% express decreased levels of methylthioadenosine phosphorylase (MTAP) mRNA. (nih.gov)
  • Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans. (nih.gov)
  • Glycogen phosphorylase (GP) is a promising molecular target for the treatment of Type 2 diabetes. (eurekaselect.com)
  • Available at https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=760 . (medscape.com)
  • Phosphorylase a is the more active R form of glycogen phosphorylase that is derived from the phosphorylation of the less active R form, phosphorylase b with associated AMP. (wikipedia.org)
  • Our multifaceted analysis further describes the kinetic implications of this in situ reactant esterification for a model phosphorylase. (chemrxiv.org)
  • The glucose-induced switch between glycogen phosphorylase and glycogen synthase in the liver is investigated by means of a theoretical approach based on a minimal, bicyclic cascade model involving the reversible phosphorylation of the two enzymes. (cellml.org)